Full Report

Industry in One Page

eClerx does not really sell "IT services." It sells domain-trained humans — supplemented by automation, AI, and proprietary process platforms — to run the back-office and middle-office of Fortune 2000 enterprises out of low-cost offshore centers. The arena is specialist Business Process Management / Knowledge Process Outsourcing (BPM / KPO) with three economic substrates: capital-markets operations for global banks, customer operations for cable/telecom and retail/media, and digital/analytics/creative production. Money is made by billing a Western client a marked-up "client rate" for an Indian or Philippines analyst's hour, multiplied by utilization, with margin coming from the gap between that client rate and fully-loaded delivery cost. The cycle starts with Fortune 2000 discretionary tech and operations budgets — when BFSI deal volumes slow or telco capex falls, hiring and pricing tighten within two quarters. The one thing beginners usually miss: this is not a voice-call BPO. The premium BPM/KPO niche eClerx plays in is a managed extension of the client's middle office — sticky once embedded, but vulnerable to two forces at once: agentic AI cannibalizing the easy tickets, and consultancies plus global integrators (Accenture, Capgemini-WNS, Cognizant, Genpact) building down-market into the same accounts.

How This Industry Makes Money

The unit of revenue is almost always the billable hour or FTE-month for time-and-materials engagements, with fixed-price work layered on top for outcome-driven scopes. For eClerx, time-and-materials produced 91% of FY2025 revenue (₹3,047 crore of ₹3,366 crore) and fixed-price the remaining 9% (₹319 crore). The pricing logic up and down the value chain is the same: an onshore buyer pays a blended rate (typically USD 20 to 50 per hour for offshore KPO, higher for onshore consulting), and the provider's job is to deliver that rate at a fully-loaded delivery cost low enough to leave 20 to 30% EBITDA.

The shape that matters: the niche where eClerx plays (specialist KPO with productized analytics) prices in the high-twenties EBITDA band, materially above generalist BPM and voice work. Regulatory complexity (KYC, trade reconciliation, MiFID, SEC reporting) and domain scarcity (someone who knows derivatives confirms or digital-shelf merchandising) raise switching costs and limit the credible vendor list to a handful of names per workflow.

Demand, Supply, and the Cycle

Demand follows enterprise discretionary budgets — BFSI deal volumes, telco capex, retail e-commerce growth, and the global pace of regulatory tightening (post-2008 Dodd-Frank, MiFID II refit, KYC and AML refresh cycles). Supply is the fresh-out-of-college India analyst pipeline, increasingly competing with global capability centers (GCCs) for the same talent. When the cycle turns, providers feel it in this order: new deal wins slow first, then utilization drops, then pricing weakens, then headcount cuts begin — usually a 2-3 quarter lag between the macro signal and the income statement.

The textbook BPM cycle: growth swings 0 to 38 percent across a decade, while operating margin moves in a narrower 22 to 31 percent band. Pricing and utilization absorb most of the cycle, not headcount, because providers protect bench in anticipation of recovery and clients value continuity in regulated workflows.

Competitive Structure

The industry is fragmented at the specialist tier and consolidating at the top. Tier-1 global integrators have a near-duopoly on the largest transformation deals (Accenture and Capgemini-WNS each above USD 50 billion), while the specialist BPM tier is a long tail of mid-cap names where eClerx ranks among the top by margin profile but is small by revenue. Competition is vertical-by-vertical: in capital-markets ops, eClerx competes with the former WNS book (now Capgemini), Genpact, and to a lesser degree TCS BPS; in digital-shelf and creative ops, with Wipro and Capgemini digital agencies, Tata Digital, and pure-play creative shops; in analytics, with LatentView, Fractal, MuSigma, and the offshore arms of Accenture and IBM. Almost no head-to-head competition is "the whole company against the whole company" — it is workflow-by-workflow, with relationship inertia keeping clients sticky once embedded.

Regulation, Technology, and Rules of the Game

Three forces are reshaping economics in real time: agentic AI that automates the easy half of the BPM workload, data-sovereignty rules that complicate cross-border delivery, and a proposed US FCC rulemaking on offshore call centers that management is actively contingency-planning around. None of these is hypothetical — each was named explicitly in the Q4 FY26 earnings call.

The Metrics Professionals Watch

For BPM / KPO specifically, the income statement is not the leading indicator. Eight operational metrics move first; the P and L follows two quarters later.

The two metrics that distinguish a winning quarter from a losing one are new ACV bookings and utilization — both leading indicators of the revenue line. Margin is almost a derivative of utilization, wage hikes, and FX, with the rest absorbed by operating leverage.

Where eClerx Services Limited Fits

eClerx is a specialist BPM mid-cap with disproportionate domain depth in capital-markets operations and a credible second leg in digital and analytics ops, sitting just below the global tier-2 BPM names by scale (Genpact USD 5 billion; eClerx USD 469 million revenue in FY26) but matching or beating them on margin (FY26 operating EBITDA roughly 26 percent versus Genpact mid-teens). It is neither a generalist BPO competing on price nor a tier-1 integrator competing on relationships — it is a "premium niche" that wins workflow-by-workflow.

What to Watch First

Seven observable signals will tell you, within two quarters, whether the industry backdrop is improving or deteriorating for eClerx specifically. Each is disclosed in the quarterly investor sheet, the transcript, or a public regulatory file.

---

Bottom Line

eClerx is a margin-premium specialist KPO, not an IT services firm — it sells domain-trained Indian and offshore analysts on a US-dollar T&M rate card, embedded inside the operating teams of Fortune 2000 banks, telcos and retailers. The right way to think about it: a 26% operating-EBITDA, 29% ROE workflow specialist with capital-markets compliance and customer operations as its two profit anchors, trading at roughly 18× earnings — a multiple below faster-growing peers (Coforge, LatentView) and below larger but lower-margin peers (FSL), in part because the market is uncertain whether agentic AI is a tailwind or a deflator. The single most underestimated point is earnings quality: FY26 generated ₹756 crore of free cash flow with FCF/PAT above 100% and OCF/EBITDA at a five-year high, on essentially zero net debt.

1. How This Business Actually Works

eClerx is, at its core, a labor-arbitrage business with a domain-expertise premium and a small but rising IP layer on top. A US or UK bank pays a USD billing rate for an Indian or Filipino analyst who maintains its KYC files, reconciles its trades, or runs its digital-shelf merchandising. eClerx's job is to deliver that hour for less than the billing rate — and to make sure the work is good enough that the bank's operations head will not switch vendors for a 5% discount.

The economics line up as four levers, in this order:

Sitting on top of the labor model are three productized IP assets the market often overlooks: Compliance Manager (KYC / financial-crime workflow), Market360 (digital-shelf analytics for retail and CPG), and Roboworx / Cogniflows (agentic-AI orchestrator now used by 15,000+ internal staff and being client-deployed). These products do not yet generate disclosed revenue lines, but they do two important things: they let eClerx win competitive RFPs against larger integrators, and they enable outcome-based pricing in pockets — for example, "we cut your KYC refresh cost 50%" — which decouples revenue from headcount.

The bargaining-power structure is asymmetric. Clients are concentrated (top-10 = 59% of revenue), procurement-led, and have outside options. eClerx's defense is embedded tenure — once an analyst pod has been running KYC for a global bank for three years, ripping it out involves regulatory risk the client will not casually take.

2. The Playing Field

eClerx does not have a single same-shape competitor. It sits in a margin sweet-spot above generalist BPM (FSL, Datamatics, Genpact) and below high-growth specialist analytics (LatentView, Coforge), with revenue scale roughly one-tenth of Genpact and one-fourth of Coforge.

Three things the peer set reveals.

First, eClerx and LatentView are the only two with PAT margins above 15% — both make their living on specialization rather than scale. LatentView is paid 30× for that quality, eClerx 18×. The gap reflects growth (LatentView 25% vs eClerx 22%) and perceived AI-disruption risk, not earnings power.

Second, Genpact, despite being 10× eClerx by revenue, earns roughly half the net margin (10.9% vs 17.2%). Scale in BPM is not the same as scale in software — past a certain point, the additional revenue comes from lower-tier accounts that pull blended margin down. eClerx's "stay small, stay specialist" strategy is economically defensible.

Third, Coforge looks structurally different — it trades at 36× because of digital IT-services growth that has little to do with eClerx's KPO economics. It is in the peer table by convention, not by economic substitution.

3. Is This Business Cyclical?

eClerx is mildly cyclical with two distinct cycle exposures: enterprise discretionary BFSI spending (capital-markets ops) and US telco/cable capex (customer operations). The cycle hits the income statement in a predictable sequence — ACV bookings → utilization → realized pricing → headcount — over two to three quarters. Margins move in a narrower band than revenue because management protects the bench and clients value continuity in regulated work.

The textbook KPO cycle: growth swings 0%–38% across a decade; operating margin moves within a tighter 22%–31% band. FY18–19 was the structural low (margin from 35% → 22%) — an idiosyncratic event tied to a large telco client and CMT margin compression, not a macro recession. The COVID year (FY20) showed almost no revenue impact but a meaningful margin dent; the post-2022 BFSI slowdown caused a one-year growth pause in FY24, which the FY26 result has now lapped.

Three cycle channels are worth distinguishing because they behave differently:

4. The Metrics That Actually Matter

Five metrics carry almost all the signal for this business. The income statement is a lagging indicator; the operating disclosures are where the next four quarters get decided. Standard ratios (P/E, ROE) tell you what the stock is — not what is happening to the business.

The heatmap shows the FY24 trough — ACV slowed, margin held but did not expand, concentration stayed elevated — and the FY26 broad recovery across every operational axis simultaneously. The recovery is what makes FY26 a credible new baseline rather than a one-off. The single weakest cell is FY25 operating margin (came in at the bottom of the guidance band); the single biggest improvement is FY26 OCF/EBITDA at 75%, the highest in five years.

5. What Is This Business Worth?

The right valuation lens for eClerx is earnings power × cash conversion through the cycle, capitalized at a multiple that reflects specialist-niche moat plus mid-cycle growth. This is not a sum-of-the-parts story — there are no listed subsidiaries, no investment book of strategic stakes, no distinct businesses with materially different economics. Customer Operations, Financial Markets, and Digital share the same revenue mechanic, the same cost structure, and the same labor pool. Trying to value them separately would invent precision the company itself does not disclose.

Value, therefore, comes down to the durability of three numbers: top-line growth, the 24–28% operating-EBITDA band, and free-cash-flow conversion.

At 18× earnings, eClerx trades at a discount to LatentView (30×), Coforge (36×) and FSL (23×), despite higher ROE than all three and a more cash-generative model than two of them. The discount has two probable explanations: lower top-line growth than LatentView and lingering investor uncertainty around AI deflation. A re-rating to 22–25× would require FY27 to deliver (i) operating margin held above 25%, (ii) ACV growth maintained at 20%+, and (iii) the first quantified disclosure of agentic-AI revenue.

FCF/PAT above 100% in two consecutive years is the single best evidence that the earnings are real and that the buyback-led capital-allocation policy is sustainable. The bear case requires explaining why this conversion rate would mean-revert downward — receivables / DSO is the only credible reason, and Q4 FY26 DSO of 81 days, while up from the ~60-day historical norm, has stabilized.

6. What I'd Tell a Young Analyst

Five things to internalize, in order of how often they matter:

Watch ACV bookings before revenue. New ACV ($46m in Q4 FY26, ~$170m for the year) leads revenue by two to three quarters. If you spot the ACV figure deteriorate while the press release celebrates the latest revenue print, you are looking at a vendor that will disappoint next quarter. This is the one number management has trained the market to focus on, and it is right to do so.

Treat top-10 client concentration as a quality signal in both directions. Falling concentration during growing revenue (the FY26 pattern — top-10 from 63–64% to 59%) is healthy diversification. Falling concentration during flat revenue is a warning — it means clients at the bottom of the top-10 are leaving. Always read the trajectory in the context of growth.

The AI question is the most important single thesis variable. Two opposite scenarios are live: (1) agentic AI deflates BPM unit economics, eClerx margins compress in 2028; (2) eClerx successfully sells outcome-priced AI-enabled workflows (the first large win was in Q4 FY26), and margin holds at 26%+ with revenue growth helped by capturing the savings as price. Mid-2027 will be the inflection — when AI revenue first gets quantified, or when it does not.

Distrust the 91% T&M / 9% fixed-price split as the future state. Outcome-based pricing on AI-enabled contracts will scramble that mix. The KPI to watch is whether average revenue per employee (revenue ÷ headcount) starts rising materially. If it does, the productized model is working. If headcount keeps growing in line with revenue, eClerx is still selling FTEs, just under new packaging.

The capital-allocation question is where you might be surprised. Management has stated buybacks are the preferred channel and the ESOP trust has been a quiet but significant buyer (₹250 crore in FY26 alone). This benefits per-share metrics without showing up as a headline buyback. Combined with bonus issue, low dividend (₹1/share), and zero net debt, shareholders are being returned to without it being legible from headline disclosure. Track diluted share count carefully — that is where the truth lives.

What would change the thesis: a final-rule US FCC NPRM that forces CMT scope onshore, a Capgemini-WNS aggressive BFSI push that wins eClerx's largest client, or a two-quarter sequence of falling ACV alongside rising DSO and top-10 concentration. None of those is present today; all of them are observable in the quarterly investor pack before they hit the income statement.

---

1. Long-Term Thesis in One Page

The long-term thesis is that eClerx is a founder-owned, specialist BPM/KPO that can compound shareholder value at a low-to-mid teens rate over the next 5-to-10 years by widening its productized-IP layer inside regulated capital-markets workflows while returning roughly 100% of free cash flow each year to a slowly-shrinking share count. The 5-to-10-year case works only if two conditions hold: (i) the operating-EBITDA margin band stays inside 24-28% through at least one full cycle that contains an AI deflation wave, and (ii) revenue per employee starts to rise materially as the productized layer (Compliance Manager, Roboworx, Market360, GenAI360) earns outcome-priced contracts rather than ceding AI productivity as client price concessions. This is not a long-duration compounder unless those two conditions hold — without them, eClerx remains a 91% time-and-materials labor-arbitrage business whose multiple anchor shifts toward Genpact's 10× and whose terminal margin trends toward 14-16%. The asset that makes the bull case underwriteable is the cash machine: ₹756 crore of FY26 FCF, FCF/PAT above 100% for two consecutive years, 34.8% ROCE on a net-cash balance sheet, founders who own 54.5% and have never sold, and a buyback engine that has returned essentially all FCF to shareholders for six years running.

2. The 5-to-10-Year Underwriting Map

The driver that matters most is the productized-IP monetization line. Capital allocation discipline, cash quality, and founder alignment have already been delivered for a decade — these are the supporting infrastructure that makes the 5-10 year underwrite possible, not the variable that compounds value. The BFSI niche is durable but small in absolute revenue terms (~35% of revenue, growing at maybe 15-20%). The single 5-to-10-year compounding lever with the magnitude to re-rate the franchise — both economically and as a multiple — is whether the eight named productized assets convert AI productivity into outcome-priced revenue rather than ceding it as price concessions. If revenue per employee rises from ₹20.5 lakh to ₹25-30 lakh by FY30-31, the bull thesis works and a multiple anchor in the 25-30× range is defensible. If it stays flat, the bear thesis holds and the multiple anchor trends toward Genpact's 10-12×.

3. Compounding Path

eClerx has compounded revenue at roughly 13% CAGR over a decade, operating profit at 12%, and FCF at 15% — with returns on capital that never dropped below 21%. The 5-to-10-year question is whether the FY26 inflection (rev +22%, FCF +40%) is the start of a sustained mid-teens compound or a single-year recovery print. The chart below shows the multi-decade arc; the table that follows lays out a base-case 5-year continuation assumption keyed to management's stated 24-28% margin band and historical growth.

The compounding mechanic is straightforward: a 15% revenue CAGR with a stable mid-band margin produces ~16% operating-profit CAGR; cash conversion sustained at 100% of PAT and a buyback that retires roughly 1.5% of float per year produces a ~17% FCF-per-share compound. Returns on capital stay above 33% across the projection because the business model is capital-light — capex runs at ~3% of revenue, depreciation roughly tracks capex, and the only meaningful "borrowings" are IFRS-16 lease liabilities. The bull-case overlay adds 200-300 bps of margin upside if AI productized contracts price out as new revenue rather than as client savings; the bear-case overlay compresses revenue growth to single digits and margin to 22-23%, producing 6-8% FCF-per-share compound, not 17%.

4. Durability and Moat Tests

A moat that has not been stress-tested at multi-year time horizons is a tailwind, not a moat. Five tests separate the 5-to-10-year compound case from the more comfortable 18-month narrative.

The five tests are deliberately mixed: two competitive (margin band, top-10 concentration), two financial (cash conversion, capital return), and one structural (productized-IP measurability). Tests 1, 3, 4 and 5 already have multi-year track records that support the bull case; test 2 — revenue per employee — does not, and is the one that has to resolve to validate the long-duration compound. Four of the five durability tests are passing and one is the single binary variable that determines whether the franchise widens its moat or has it eroded over the next decade.

5. Management and Capital Allocation Over a Cycle

eClerx's management story is unusually clean by Indian mid-cap standards, and the capital-allocation pattern is the most underwritten signal for a 5-to-10-year holder. Two Wharton/Booth co-founders own 54.5% of the company in personal capacity (not through layered promoter vehicles), have held since the 2007 IPO at ₹315, and have never trimmed a share in 26 years. PD Mundhra (Whole-time Director) draws ₹1.7 crore in salary with no bonus and no ESOPs — extraordinary restraint for a 27% owner. Anjan Malik is non-executive but chairs Risk Management. In May 2023 the board appointed Kapil Jain — ex-Genpact, UK-based — as the first non-founder CEO; the founders stepped off earnings calls a year later when the May-2024 strategy reset was unveiled, and the credibility check that followed (10 of 14 valuation-relevant promises kept under Jain, margin band held through wage cycles, FY26 the strongest year on record) materially de-risks the post-founder operating regime.

The capital-allocation track record is the bull case in concentrated form. Over FY18-FY26 the company returned approximately ₹2,930 crore through buybacks plus another ~₹35 crore in dividends — against roughly ₹4,217 crore of cumulative free cash flow. The structural choice — buybacks over dividends, organic over inorganic, modest bolt-ons (Personiv FY19, Cognicor FY24) over transformational M&A — is what a 35%-ROCE saturated-core specialist should do. The founders sit out every buyback, so their per-share economic interest compounds for free; shareholders are being returned to without it ever showing up as a headline buyback yield (current dividend yield is 0.04%). The one unanswered question for the 5-to-10-year horizon is succession: Jain's first five-year term ends in FY28, his ESOPs are out-of-the-money at ₹2,302 strike, and the next CEO's discipline around the 24-28% margin band and the buyback cadence is the variable that re-prices the franchise multi-year.

6. Failure Modes

A long-duration thesis without named failure modes is wishful thinking. Six failure modes have specific early-warning indicators, can be observed in public disclosures, and are weighted by severity rather than dressed up as generic execution risk.

7. What To Watch Over Years, Not Just Quarters

The signals below are sized for a multi-year holder, not a quarterly trader. Each is observable in public disclosures, has a specific time horizon longer than 12 months, and is mapped to validation versus weakening evidence for the long-term thesis.

The five multi-year signals are deliberately ordered by information value. Signals 1 and 3 are the same question expressed differently — does productized IP convert AI productivity into vendor revenue or cede it as client savings — and dominate the 5-to-10-year economics. Signals 2 and 4 are the durability proofs that the niche survives the structural threats it actually faces (AI deflation, Capgemini-WNS). Signal 5 is the per-share compounding test that converts the operating result into shareholder return through the buyback engine.

---

Competitive Bottom Line

eClerx has a real but narrow moat in capital-markets back-office operations, layered on top of a more contested mid-cap BPM body. The evidence: an Everest Group Leader & Star Performer ranking in Capital Markets Operations (Sep-25), a Chartis category leader in Client Lifecycle Management for CIB, eight of the world's ten Tier-1 banks as clients, and a 25.5% operating-EBITDA margin that runs roughly 10 percentage points above generalist BPM peers (Genpact 14.8%, FSL 16.0%, Coforge 18.0%). The moat narrows quickly outside that niche — in customer operations for cable/telecom, in digital-shelf, and in pure-play analytics, eClerx is one of several credible vendors per workflow, and the price-discovery is sharper. The competitor that matters most over the next 18 months is Capgemini's newly-acquired WNS book (July 2025): a tier-1 integrator now owns the closest historical pure-play KPO peer, sitting on top of the same Tier-1 BFSI clients with a bundled consulting-plus-ops sales motion eClerx structurally cannot match. The question this tab tries to answer is whether eClerx's specialist economics survive that flanking move, plus the parallel pressure from Genpact's agentic-AI build.

The Right Peer Set

The five-company peer set is built to triangulate four different competitive vectors, not to find lookalikes. eClerx has no listed twin: the closest historical comp (WNS Holdings) was acquired by Capgemini in July 2025 and de-listed. Each remaining peer tests a specific question about eClerx's economics.

The four vectors:

The chart maps the trade-off precisely. LatentView and eClerx own the right half of the picture — the only two peers above 20% operating margin. LatentView is paid 30× for that margin and eClerx 18×. The discount is real but the underlying earnings power is structurally similar; the gap is about perceived growth durability and AI-disruption risk, not about today's economics.

Where The Company Wins

Four concrete advantages, each tied to evidence the reader can verify.

1 — Margin premium that holds up across the peer set. eClerx's FY26 25.5% operating-EBITDA margin is above every listed BPM peer reachable from the staged data. Genpact, with 12× the revenue, earns 14.8%. FSL, with 2.3× the revenue, earns 16%. The closest size-and-mix peer (Datamatics) earns 19%, even though Datamatics is also categorized as BPM-plus-data. The only peer with comparable margin is LatentView (22%), and LatentView is a much smaller, narrower pure-play. Source: peer income statements in data/competitors/*/income.json plus Screener snapshots.

2 — Dominance in regulated capital-markets workflows. eClerx claims to serve eight of the top-ten global Tier-1 banks (eclerx.com homepage). Everest Group's 2025 Capital Markets Operations PEAK Matrix named eClerx a Leader and Star Performer (Sep-25 press release), citing "specialization and depth" in middle-office and trade operations. Chartis ranks eClerx a category leader in CLM for CIB. The Fayetteville NC FCC Center of Excellence — staffed with transitioning US military personnel for an onshore alternative — is a credentialed asset Genpact and Indian BPM peers do not have. This translates into pricing power on regulated workflows (KYC refresh, financial-crime compliance, trade lifecycle) where buyers care more about defect rates and audit trails than unit cost.

3 — Productized IP that supports outcome-based pricing. Compliance Manager, GenAI360, DocIntel, Market360, FLUiiD4, Merchandiser+, QA360, Roboworx CogniFlows — eight named products spanning KYC workflow, GenAI orchestration, digital-shelf analytics, and creative production. The Q4 FY26 first large agentic-AI win is the early evidence that this IP can attach outcome-priced contracts that decouple revenue from headcount. Genpact has Cora and over 7,000 AI builders, but at $5B revenue Genpact's incremental AI revenue gets diluted; for eClerx at $432M, even modest agentic-AI attach can move the mix. Source: eclerx.com product pages, Q4 FY26 earnings transcript, Genpact 10-K FY2025.

4 — Earnings quality and capital structure. Per the Warren tab, FY26 generated ₹756 Cr free cash flow with FCF/PAT above 100% for the second consecutive year and OCF/EBITDA at a 5-year high of 75%. The balance sheet carries zero meaningful debt. By contrast, FSL is part of a leveraged group, Coforge took on borrowings for the Cigniti deal, and Datamatics carries ₹221 Cr of borrowings. eClerx's combination of margin × cash conversion × net-cash means the entire ROCE figure is real returnable cash, not accruals or capex-light optical earnings.

Where Competitors Are Better

Each weakness is paired to a specific competitor and a specific reason.

The single most uncomfortable peer comparison is the growth-velocity gap with Coforge. Coforge has effectively bought growth and is being rewarded with a 36× P/E. eClerx has chosen organic discipline and is priced at half that multiple. Two different strategies are being run live, and the next 18 months will reveal whether Coforge's inorganic stack assembles into durable earnings or unwinds in margin compression — Coforge's FY25 operating margin already softened to 14% before recovering to 18% in FY26, suggesting digestion risk.

The second uncomfortable comparison is agentic AI. Genpact's 10-K reads as if AI is the company's primary growth axis: separately-disclosed Advanced Technology Solutions revenue line, 7,000 builders, Cora platform, agentic operations products. eClerx has the products (Roboworx, GenAI360) and a first agentic-AI win in Q4 FY26, but does not yet disclose AI revenue separately. Until that disclosure exists, an investor cannot quantify whether eClerx is keeping pace.

Threat Map

Five threats ranked by 18-month severity. Industry-wide pressures (wage inflation, FX) are excluded — these are competitor- or substitution-specific.

The heatmap shows the two genuinely dangerous arrows. Capgemini-WNS peaks in the 6-18 month window as the integration closes and Capgemini begins selling the combined book into its consulting accounts. Genpact's agentic-AI threat peaks later because revenue cannibalization takes longer than competitive RFP losses. Together, those two threats define the next 24 months. The FCC NPRM is a binary event whose timing is controlled by Washington, not by competitors — it slots into the same window if finalized.

Moat Watchpoints

Five measurable signals that will move first if the moat is strengthening or weakening. Each is disclosed in eClerx's quarterly investor pack, the transcript, peer filings, or a public regulatory file.

---

Current Setup & Catalysts

1. Current Setup in One Page

The stock is sitting on its 52-week low at ₹1,351 after a 72% headline collapse — half mechanical (a 1:1 bonus issue allotted 16 March 2026 doubled the share count) and half a real ~46% post-bonus de-rate from the February high — even as eClerx printed its strongest fiscal year on record (FY26 revenue ₹4,117 cr +22%, PAT ₹706 cr +30%, FCF ₹756 cr +40%, EBITDA margin 25.5%, ROCE 35%). The recent setup is mixed, not quiet: fundamentals just inflected, the tape is broken, and the next 12 weeks will resolve three live questions — (i) does Kapil Jain's "Q1 FY27 will be stronger sequentially than Q4" promise on the 14 May call land, (ii) does the FY26 annual report (likely Jul–Aug 2026) close out the unbilled-receivables KAM and Rule 11(g) audit-trail flags, and (iii) does the first "large-scale Agentic AI" contract promised for Q1 FY27 actually print a measurable revenue line. Beyond that, the FCC 26-16 NPRM on offshore call-centre routing (adopted 27 March 2026) is the one regulatory tail that touches the largest single vertical (~45% of revenue), with no final-rule timeline yet. The near-term calendar is light on hard dates but heavy on thesis-resolving content: one earnings print (Aug 6, 2026), one annual report, one AGM, and one regulatory comment window all land in the same six-month window that the bull-bear debate needs to settle.

2. What Changed in the Last 3–6 Months

The recent narrative arc compresses into seven decision-relevant events. The stock spent four months absorbing a parabolic blow-off, a mechanical bonus issue, a record FY26 print, and the adoption of the first regulatory rule that touches its largest vertical — all without a single piece of governance, fraud, or restatement noise.

What the market used to debate was whether the FY24-25 margin drift to 24% was structural; that has been answered — FY26 closed at 25.5% with H2 at 27%, the wage cycle is absorbed, and debtor days have collapsed from 88 to 59. What the market is debating now is the durability of the new margin band against three new threats that did not exist nine months ago: AI deflation showing up as buyer-side price concessions, the Capgemini-WNS bundled-integrator flanking move (Capgemini delisted WNS in July 2025), and the FCC 26-16 NPRM hitting the single largest vertical. The two unresolved questions are whether the productized-IP layer earns AI productivity as new revenue (the Q1 FY27 disclosure window) and whether the FCC final rule arrives faster than Cairo/Lima/Fayetteville can scale.

3. What the Market Is Watching Now

The live debate sits inside the next three earnings cycles, not inside any single regulatory or governance window. Sell-side is unanimously Buy (8 of 9), Nomura just raised FY27 EPS by 2.4% on the Q4 print, and the Trendlyne/MarketScreener consensus target (₹1,859) implies +37% upside to today's print. The bear case is therefore reliant on a fundamental flinch — a margin print below 24%, an AI disclosure that fails to materialise, or a forensic re-rate from Watch to Elevated — rather than a positioning unwind that has already happened.

4. Ranked Catalyst Timeline

The calendar is thin on hard dates but rich on thesis content. Q1 FY27 (Aug 6) is the only confirmed hard date within 90 days; the FY26 annual report window (Jul–Aug) and AGM (Sep) are soft windows anchored to historical pattern, not BSE-filed intimations. The FCC NPRM and Capgemini-WNS catalysts are rolling — they update the underwrite slowly through Q3-Q4 CY26 rather than in a single print. The single observation a PM should track is the H1 FY27 sequence: if the Aug print delivers margin durability + AI revenue line, the Nov print bottoms F&L, and the Feb print extends ACV growth, the bull thesis has earned three independent validations inside one year.

5. Impact Matrix

Two of the five impact-matrix items resolve the 5-to-10 year thesis directly (productized-IP cadence; FCC final rule), one closes a current forensic overhang (FY26 annual report), one validates the immediate margin-band durability question (Q1 FY27), and one preserves the per-share compound mechanic (AGM/buyback). The Q1 FY27 print is the only item that touches both the durable thesis and the near-term tape — which is why it dominates the next 12 weeks of the underwrite even though it is, mechanically, an ordinary quarterly print.

6. Next 90 Days

The 90-day window is calendar-light but information-dense: one hard-dated print (Q1 FY27, ~56 days), one soft-dated annual report (Jul-Aug 2026), and one rolling regulatory window. There is no investor day announced, no analyst meet beyond the routine intimations of 18-19 March 2026, no scheduled product launch with a confirmed date, and no transaction milestone. The lack of a hard-event sequence after Aug 6 means the Q1 FY27 print disproportionately controls the autumn tape; the next equally weighted catalyst is Q2 FY27 (projected 5 Nov 2026) — outside the 90-day window but inside the 6-month frame.

7. What Would Change the View

Three observable signals over the next six months would force the durable underwrite to update. First, the Q1 FY27 print on Aug 6 must hold the operating EBITDA margin at or above 24% AND deliver sequential USD revenue growth above 2% — failure on either side, especially margin below 24%, refutes the durable 25-28% band that the entire bull case (and Nomura's ₹2,220 target) is built on. Second, the FY26 annual report (Jul-Aug 2026) must show unbilled receivables snapping back toward 5-6% of revenue and a Rule 11(g) audit-trail clean reading in Price Waterhouse's second year — that combination closes out the only forensic concerns the short-thesis register could weaponize. Third, the first quantified outcome-priced or agentic-AI revenue line must appear in disclosures by Q2 or Q3 FY27 — without it, the productized-services narrative reads as repackaged T&M and the multiple converges to Genpact 10-12×. The FCC NPRM and Capgemini-WNS catalysts are slow-moving and unlikely to resolve inside six months; they raise the variance band on the FY27 path but do not flip the central case alone. The cleanest summary is that the bull case has earned the right to be believed on margins and capital allocation, but still has to prove the AI monetisation — and the next 12 weeks are when that proof either appears or does not.

---

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the backward-looking fundamentals are clearly top-quartile (FY26 revenue ₹4,117 Cr +22%, PAT ₹706 Cr +30%, FCF ₹756 Cr at 107% of PAT, ROCE 34.8%, 0 forensic red flags) and the ₹1,351 print at 18× TTM is the cheapest entry in five years once the 1:1 bonus issue (allotted 16 Mar 2026) is unwound. But the bear is right that the moat's durable variable — does eClerx capture AI productivity as new outcome-priced revenue or cede it as T&M price concessions — is not yet measurable, and a 91% time-and-materials book with flat revenue-per-employee at ₹20.5 lakh for three years is structurally exposed if it cedes. The tension that decides the trade is therefore monetisation of AI productivity, not the bonus-issue optics or the forensic Watch score. A quantified Agentic-AI revenue line (even ≥3% of group) plus an FY27 operating EBITDA print held inside the 25–28% band would validate the bull setup; the absence of either through H1 FY27, especially against an adopted FCC NPRM hitting the 45%-of-revenue Customer Operations vertical, would invert the conclusion.

Bull Case

Bull target ₹2,000, method 22× FY27E EPS ~₹91 (consensus PAT growth 15–17% on FY26 ₹706 Cr divided by ~9.40 Cr post-bonus shares), timeline 12–18 months — anchored to the company's own five-year average multiple, between Emkay's ₹1,800 (~20×) and Nomura's ₹2,220 (~25×). Disconfirming signal: two consecutive quarters of operating EBITDA margin below 24% combined with top-10 client concentration ticking back above 62%.

Bear Case

Bear downside target ₹900, method 12× degraded FY27 EPS ~₹75 (Genpact 10× anchor + ~20% quality premium; revenue growth decelerates to ~10%, op EBITDA margin slips to 22–23%, FCF/PAT mean-reverts to ~90% as unbilled drift normalises), timeline 12–18 months. Cover signal: two consecutive quarters of revenue/employee rising >10% YoY and a quantified agentic-AI revenue disclosure ≥5% of group revenue.

The Real Debate

Verdict

Lean Long, Wait For Confirmation. Bull carries more weight on the backward evidence — FY26 is a record print on revenue, PAT, FCF, ROCE, and capital return, the forensic verdict is clean (22/100 Watch, zero red flags, unqualified PWC opinion in year one), and the 18× entry multiple plus bonus-issue mechanics make the −72% headline materially overstate the fundamental damage. The single most important tension is whether AI productivity flows to eClerx as new outcome-priced revenue or to clients as T&M price concessions — and on this, the bear is correct that the evidence does not yet exist: revenue/employee has been flat at ₹20.5 lakh for three years, 91% of revenue is T&M, and no AI revenue line has been disclosed while a global peer separately reports $1.2B. The bear could still be right because the FCC NPRM is now adopted (not tail), Capgemini-WNS is a real Tier-1 flanking move inside the BFSI niche, and a three-year flat output-per-head is consistent with quiet deflation that only shows in the P&L after the lag. The durable thesis breaker is two consecutive quarters of operating EBITDA margin below 24% with no quantified Agentic-AI revenue disclosure through H1 FY27 — that combination converts AI deflation and integrator wallet-share take from narrative into reported income. The near-term evidence marker — the first quantified outcome-priced revenue print on the Q1 or Q2 FY27 call — is the lower-stakes observable that confirms the bull setup if it arrives; its absence alone is not yet the breaker, but does extend the "Wait" portion of the verdict.

---

I’ll fix only the weaknesses query by making every UNION ALL branch return the same columns the table already uses: sort_key, weakness, why_it_matters, evidence, and severity.—

title: "Moat — eClerx Services Limited (ECLERX)"

1. Moat in One Page

Verdict: Narrow moat. eClerx has a real, durable advantage in regulated capital-markets back-office workflows — KYC, financial-crime compliance, trade lifecycle, reference data — for global Tier-1 banks. The protection comes from three reinforcing sources: switching costs that compound the longer an analyst pod stays embedded; specialist domain expertise that takes years to rebuild; and a small but real productized-IP layer (Compliance Manager, Roboworx, Market360) that supports outcome-based pricing. Outside that BFSI niche — in customer operations for cable/telecom, digital-shelf, and pure-play analytics — eClerx is one of several credible vendors per workflow and the price-discovery is sharper. The moat works in the numbers (25.5% operating EBITDA versus Genpact 14.8%, 34.8% ROCE versus peers 16–23%, FCF/PAT above 100% for two years), but it has been tested and dented before: operating margin compressed from 37% in FY16 to 22% in FY19 when a single large telco client renegotiated, proving the niche is defendable, not unassailable.

A moat is a durable economic advantage that lets a company protect returns better than its competitors. For eClerx the question is whether the 10-percentage-point operating-margin premium over generalist BPM survives two specific pressures: agentic-AI deflation of routine workflows, and Capgemini's July 2025 acquisition of WNS (the closest historical pure-play KPO peer) sitting on top of the same Tier-1 BFSI clients with a bundled consulting-plus-tech-plus-ops sales motion eClerx cannot match.

2. Sources of Advantage

For each candidate moat source, the question is the same: is it company-specific, is it visible in numbers, and could a well-funded competitor copy it within three years?

The picture that emerges is three real sources (switching costs, intangible domain credentials, embedded workflow) plus one in-progress source (productized IP). The labor-arbitrage premium is industry-level, not company-specific. Network effects, regulatory licensing, and scale economies do not apply. The honest narrow-moat rating rests on the first three, and the durability question is whether AI deflation hollows out the embedded workflow source faster than productized IP can replace it.

3. Evidence the Moat Works

Eight pieces of evidence test whether the alleged moat shows up in business outcomes. The mix is deliberately set up to include both supporting and refuting evidence — a real moat earns its rating despite the counter-evidence, not in its absence.

The evidence ledger is not unanimous. Five items support the narrow-moat rating, two refute it, and one is mixed. The largest single counter-evidence is flat revenue per employee — the strongest test of whether the company has converted its claimed productized IP into actual decoupling of revenue from headcount. Until that ratio starts rising materially, the productized-IP source is a thesis, not a moat. The FY16–FY19 margin compression is the second key refutation: the moat has been broken before by a single-client renegotiation, which means the durability score must be middling, not high.

4. Where the Moat Is Weak or Unproven

The honest list of weaknesses is the most important section on this page. A narrow-moat rating that does not name what could destroy it has not earned the rating.

5. Moat vs Competitors

The peer comparison anchors the moat rating against the four most relevant competitive vectors. Comparing across competitors of different scale and mix is harder than usual here because eClerx has no listed twin — WNS was de-listed when Capgemini acquired it in July 2025, removing the cleanest historical mirror.

The chart makes the case visually: eClerx sits alone in the top-right quadrant on both operating margin and return on capital employed. LatentView matches on margin but at much lower ROCE; Coforge matches on ROCE but at materially lower margin; Genpact and FSL fail both tests. The 34.8% ROCE on 25.5% operating margin is what a narrow moat looks like in the numbers. The risk to the rating is that the future may not look like the past five years — the comparable table will look different in 2028 if AI deflation hits BPM unit economics evenly across the peer set.

6. Durability Under Stress

A moat that has not survived stress is not a moat — it is a tailwind. Six stress cases test whether eClerx's moat would hold against the kinds of shocks BPM specialists actually face.

The stress table summarises the durability rating cleanly: the moat holds against four of six tested stresses (recession, Capgemini-WNS share threat on in-place mandates, single-client loss in the long run, management transition) and is open on two (AI deflation, FCC NPRM). The two open stresses are precisely the live thesis questions for the next 18 months. The historical FY18-19 telco episode caps the durability rating — a moat that has been broken once is by definition narrow, not wide, even after it re-asserted.

7. Where eClerx Fits

The moat lives in specific places inside the company. Not every segment, customer group, or product line is moated equally. Treating the whole company as a single block over-rates the protected workflows and under-rates the contested ones.

The most important takeaway: the moat is concentrated in Financial Markets, not spread evenly. Roughly 35% of revenue carries narrow-to-wide moat protection; the larger Customer Operations vertical carries narrow-to-none; Digital is largely contested. A reader who buys the whole company on the moat rating should remember that two-thirds of the revenue base is operating in less protected ground. The bull case is that Financial Markets compounds at 15-20% and dilutes the unprotected mix; the bear case is that Customer Operations decompresses faster on AI/FCC pressure than Financial Markets can grow.

8. What to Watch

Six signals will move first if the moat is strengthening or weakening. Each is observable in the quarterly investor pack, the earnings transcript, peer filings, or a public regulatory file — no insider channels needed.

The first moat signal to watch is revenue per employee — that is the single number that will tell you, ahead of margins or returns, whether the productized-IP layer is becoming a real moat source or remaining a positioning narrative.

---

The Forensic Verdict

eClerx Services Limited screens as a Watch (22/100) — a cleanly-cash-generative, founder-controlled mid-cap KPO whose income statement, cash-flow statement, and balance sheet reconcile to each other across more than a decade. The two items that stop this from being a flat-out "Clean" grade are (1) an FY2025 jump in unbilled revenue from ₹207 Cr to ₹294 Cr (+42% against revenue growth of 15%) — flagged as a Key Audit Matter by the newly-appointed statutory auditor — and (2) Rule 11(g) audit-trail gaps across multiple accounting systems for most of FY2025. Offsetting that, eleven-year average CFO/Net Income sits at ≈1.10, FY2026 receivable days reverted from 86 to 59, the auditor rotation (S.R. Batliboi → Price Waterhouse) was a mandatory two-term expiry rather than a stress event, and no restatement, regulatory action, or material weakness opinion has been issued. The single data point that would most change the grade: FY2026 standalone unbilled receivables — if they remain at or above 8% of revenue, this becomes Elevated; if they snap back toward 5-6%, it becomes Clean.

Negative accrual ratio means CFO exceeds reported net income — a quality signal, not a stress signal.

Shenanigans Scorecard

Breeding Ground

The structural conditions look ordinary for a founder-controlled Indian listed IT-services company, with one mild positive (independent chair, independent audit chair) and one mild negative (concentrated promoter holding plus a high inter-company services flow with the US sales subsidiary). Nothing here pre-disposes the financials to manipulation, but a forensic reader must keep the eClerx LLC related-party flow in view because it is the conduit through which group revenue is booked.

The compensation structure deserves a positive note: founder PD Mundhra draws a flat ₹1.7 Cr salary with no performance bonus, and Group CEO Kapil Jain is paid via the UK subsidiary on a £650K salary with a bonus capped at the prior-year basic. That mutes the classic shenanigans incentive — managers paid in aggressive adjusted-EBITDA bonuses — and there is no evidence of a CEO compensation structure that would reward stretching reported earnings.

Earnings Quality

Reported earnings convert into cash on a multi-year average ratio above 1.0 and the accrual ratio is consistently negative — the cleanest possible signal that net income is not being inflated by accruals. The one area worth attention is unbilled revenue, which jumped 42% in FY2025 (₹207 Cr → ₹294 Cr) against revenue growth of 15%. Price Waterhouse, in its first year as statutory auditor, flagged this as a Key Audit Matter and walked through aging and subsequent-billing testing. The auditor issued an unqualified opinion, so the FY25 number was substantiated, but the ratio of unbilled to revenue rose from 7.1% to 8.7% — a level worth watching in FY26.

CFO has tracked or exceeded net income in 9 of the last 12 fiscal years, including 1.21x in FY25 and 1.24x in FY26. No accrual build-up. No reserve gymnastics. No silent earnings smoothing.

The visual gap is small but the ratio matters. Unbilled grew 6.0x faster than revenue in FY25. For a time-and-materials BPM business, unbilled revenue is genuine — work performed in March that has not yet been invoiced — but a 42% step in a single year is the classic "watch this" signal. Two facts reduce the temperature: the new auditor performed effort-estimate and subsequent-billing testing, and the audit opinion is unmodified.

Other income is running 8-11% of operating profit in recent years. Read against a treasury portfolio of ₹1,048 Cr (cash + bank balances + investments at end-FY25), that yield is ordinary, not an earnings prop. There is no evidence of one-time gains, JV income, or below-the-line items being recycled into operating earnings.

Capex runs below depreciation in every year shown. There is no expanding bucket of "other non-current assets" hiding operating costs. The lease accounting under Ind AS 116 produces a right-of-use asset of ₹325 Cr and a matching lease liability of ₹358 Cr at end-FY25 — these flow correctly through depreciation and finance costs, not through hidden capitalisation.

Cash Flow Quality

Operating cash flow is sourced from collections and a normal-looking working-capital cycle, not from supplier stretch or factoring. The FY25 step-up in CFO (+24%) was matched by a step-up in revenue and net income, and was not driven by any one-off — there is no factoring disclosure, no receivable sale, no supplier-finance program, no tax-refund spike.

The debtor-day spike in FY24 (88 days from 61) and the partial reversal in FY25 (86) are the most visible balance-sheet whisper in the dataset. Combined billed plus unbilled receivables / revenue ran 24-25% across FY24-FY25 against a 16-17% historical norm. FY26 debtor days collapsed back to 59 — a cleanly favourable signal that the FY24 step was timing-related rather than a structural collection problem. Working-capital days, however, jumped to 85 in FY26 driven by other liabilities expansion; this is a screener-derived calculation and likely reflects the larger ESOP-trust liability balance, not an operating problem. Read together, the cash-flow statement is doing what it should: collections are happening, but not in a way that fingerprints any cosmetic CFO inflation.

The FY24 investing-cash-flow outflow of ₹483 Cr looks dramatic in isolation but is largely net redeployment of treasury into mutual funds, not acquisitions. FY25 investing turned positive (+₹143 Cr) as a portion of those funds was realised. This is treasury behaviour, not an acquisition-aided CFO story.

Metric Hygiene

eClerx does not run an aggressive non-GAAP framework. Management reports EBITDA, EBITDA margin, dollar revenue growth (constant currency and reported), deal wins, and headcount. There is no "adjusted EBITDA" that excludes recurring stock-based compensation, no "cash earnings", no organic-growth definition that shifts year-to-year, and no metric that has been quietly dropped after deteriorating.

The deal-wins figure should be tracked. Indian IT-services companies routinely conflate TCV-over-life with annualised revenue, and ECLERX's $140M FY25 deal-wins number is not reconciled to revenue. There is no allegation of misstatement here — only that the metric is the kind that can be redefined without disclosure. Track the deal-wins to actual revenue growth: $140M deal wins against $397.6M revenue suggests a healthy backlog if the TCV horizon is 2-3 years, but the calculation needs a definition.

What to Underwrite Next

Five items to track. Two would move the grade up, three would move it down.

Track 1 — Unbilled receivables ratio in the FY2026 balance sheet. Watch the line "Trade receivables — Unbilled" in the consolidated balance sheet. FY25 closed at ₹294 Cr (8.7% of revenue). A return to 5-6% of revenue (the FY21-FY23 range) would clear the FY25 step-up as a timing event and move this file toward "Clean". A persistence at 8% or above, or a further rise, would push the rating to Elevated and require diligence into whether time-and-materials billing cycles have structurally lengthened.

Track 2 — FY2026 Rule 11(g) audit-trail disclosure. The Companies (Audit and Auditors) Rules mandate audit-trail edit-logging effective FY24. ECLERX's FY25 disclosure documented a partial-year gap. Confirm that the FY26 auditor's report contains no Rule 11(g) qualification or that the gaps were remediated for the full year.

Track 3 — Deal-wins definition. If the company changes the TCV horizon or starts reporting ACR-based wins instead of TCV, treat that as a metric-hygiene yellow flag and require reconciliation to revenue growth.

Track 4 — Related-party flow with eClerx LLC. The FY25 ₹356 Cr sales/marketing service charge to the US wholly-owned subsidiary is meaningful (≈10.6% of consolidated revenue). It is eliminated on consolidation, but transfer-pricing disputes are the single most common Indian-IT-services tax exposure. Monitor for any tax demand, advance-pricing-agreement amendment, or contingent-liability change.

Track 5 — Treasury redeployment. With ₹1,048 Cr+ of cash and investments and ongoing buybacks (FY25: 13.75 lakh shares retired) plus a January 2026 1:1 bonus issue (cosmetic, no value change) and an October 2025 buyback program in tranches, watch the equity-share-capital line for unexplained jumps. The FY26 jump from ₹47.65 Cr to ₹92 Cr is the bonus issue capitalising reserves — a reader who does not know this could mistake it for a cash equity raise.

Bottom line for a PM. The accounting risk here is a footnote, not a valuation haircut. Position sizing does not need to be limited on forensic grounds; covenant comfort is irrelevant because the company carries no term debt; required margin of safety does not need to expand from accounting concerns. The forensic file becomes thesis-relevant only if (1) unbilled revenue persists above 8% of revenue, or (2) a Rule 11(g) qualification reappears in FY26, or (3) a transfer-pricing dispute with US tax authorities surfaces around the eClerx LLC service-fee flow. Until then, treat eClerx as a clean compounder whose forensic profile is consistent with its founder-stewardship and conservative capital-allocation history.

---

Governance grade: A–. Two founders still own 54.5% of the company between them, take no Indian salary, sit out every buyback, and the board has been deliberately refreshed under an independent Chair. The only real tension is the Group CEO's compensation routed through the UK subsidiary — economically defensible, governance-cosmetically odd.

1. The People Running This Company

eClerx is a founder-controlled BPM/KPO. Strategy and capital allocation sit with two Wharton/Chicago Booth co-founders who have run the company for 26 years and never sold a share. Day-to-day execution sits with a hired Group CEO whose pay is benchmarked against UK BPO peers and whose interests are linked to the share price through ESOPs.

PD Mundhra and Anjan Malik are the story. They incorporated eClerx in March 2000, listed in 2007 at ₹315/share, and have held an essentially unchanged founder block ever since. Both are credible operators — Mundhra runs the company day-to-day as Whole-time Director and chairs the CSR committee; Malik stepped off executive duty years ago but stayed on the board as a non-executive promoter and now chairs the Risk Management Committee. Their combined economic interest in the float (~₹6,930 crore at the current ₹1,351 price) dwarfs any salary line; they have effectively been paid in stock for 26 years.

Kapil Jain was hired as Group CEO in May 2023 — the first non-founder CEO. He sits on the board as Managing Director but his employment, salary, and ESOPs are administered through eClerx Limited (UK). The Indian listco pays him nothing directly; cost recovery happens via transfer pricing. This is a perfectly legal structure for an India-headquartered group with a UK-resident CEO, but it does mean the headline Indian remuneration table reads "Nil" against his name, which makes pay-vs-performance harder to read at first glance.

Srinivasan Nadadhur (CFO) and Pratik Bhanushali (CS) round out the KMP. The senior management refresh during FY2025 was modest — the Head of HR turned over (Amir Bharwani out Nov 2024, Asma Sultana in March 2025), with no other executive departures. Stable bench.

2. What They Get Paid

Mundhra at ₹17.06M is the cheap line. That is roughly 0.24% of FY2025 net income — extraordinarily low for a 50%+ owner-operator. He takes no bonus, no ESOPs, no perks beyond salary. The arrangement is consistent with what you would expect from a founder who is being paid in equity appreciation and buyback-driven concentration, not in cash.

Kapil Jain at ~₹125M (£650k base + £460k bonus + 225,000 ESOPs at ₹2,302 strike) is the real CEO comp line. That is high for an Indian-listed mid-cap (Mundhra at TCS-equivalent scale would earn 3–4× this), but consistent with hiring a senior, London-based CEO out of a global BPO talent pool. The ESOP grant (225k options at FY25 grant date — roughly 0.25% of equity) and the bonus floor of £650k are the alignment levers. The Indian-listco-pays-nothing structure raises a transfer pricing audit risk but no economic-substance concern.

Independent directors are paid at the statutory ceiling (₹3.5M commission + ₹0.3M sitting fees). With six independents, total board pay (excl. executive directors) is ~₹23M — well within 1% of net profit and the cleanest possible structure: no ESOPs to independents since FY2014, no commissions tied to share price.

3. Are They Aligned?

This is where the case is made. eClerx has the cleanest alignment profile in Indian mid-cap IT services: founder ownership of 54.5%, consistent buybacks that promoters never join, no related-party leakage, and a capital allocation policy that explicitly prefers buybacks over dividends.

Ownership and control

Promoter holding moved from 53.61% to 54.53% across 11 quarters — entirely through promoter non-participation in the FY2024 buyback (₹3,850M completed July 2024) and the FY2026 buyback (₹3,000M completed Jan 2026, 625,000 shares extinguished). Domestic mutual funds (DII) own 24–26% and are the largest non-promoter class — HDFC Asset Management alone holds 8.4%. Retail/public ownership has actually compressed from 11% to 7.5%, indicating institutional crowding-in.

Insider activity, dilution, and buybacks

Over the last six years eClerx has returned essentially all available cash to shareholders. Total FY26 cash from financing was ₹(6,220) crore — nearly identical to operating cash flow of ₹8,730 crore. FY26 also includes a 1:1 bonus issue approved by the board in January 2026 (equity capital doubled from ₹47 crore to ₹92 crore on the balance sheet). Bonus issues are economically neutral but improve liquidity and are a positive signal of confidence in sustained dividends/buybacks at twice the share base.

ESOP dilution is contained. The Employee Welfare Trust held 1.46% as of March 2025 and has been a small net seller (e.g., 14,410 shares at ₹1,558 on May 27, 2026). The 225,000 options granted to the CEO at ₹2,302 strike are out of the money at the current ₹1,351 price — there is no near-term overhang.

Related parties

The related-party register lists the standard subsidiary roll-up (eClerx LLC USA, eClerx Limited UK, Personiv, CongnIcor, Privani) plus the UK sub paying CEO compensation. The audit committee approved all transactions as arm's-length and ordinary course. There are no founder-owned vendor entities, no promoter-owned real estate leases, and no associate companies with directors' relatives. By Indian mid-cap standards this is unusually clean.

Skin in the game

The 9/10 reflects: 27% personal stakes each for the two founders (~₹3,460 crore each at the current price), no founder selling in 26 years, promoters not participating in any buyback, a consistent multi-year track record of capital return, and no value-leaking related-party structure. The single point off is the optionality embedded in routing the Group CEO's compensation through the UK sub, which limits the public Indian disclosure of his total comp.

4. Board Quality

The April 1, 2024 board refresh is unusual in scale: a new independent Chairperson (Kekre), a new Audit Committee Chair (Majmudar, appointed Apr 1, 2024), a new NRC Chair (Naval Bir Kumar), a new CSR/ESG Chair (Naresh Chand Gupta), and Anjan Malik (promoter) reassigned to chair Risk Management. Five committee chairs changed simultaneously. The proxy frames this as scheduled rotation under Companies Act tenure limits; from outside it reads as a deliberate independence reset.

Independence — real, not just formal

Six of nine directors are non-executive independent — above the SEBI minimum. More importantly, the Chair is independent (Kekre, 2nd term), and the Audit and NRC chairs are both independent and held by directors with no prior connection to the founders. The Code of Conduct flagged no material related-party transactions involving directors. All independent directors have completed the IICA proficiency test as required by the 2019 SEBI rules — boxes ticked correctly.

Real expertise gaps

Financial-markets and capital-allocation expertise are oversupplied; AI/technology depth is light. With analytics and GenAI becoming explicit growth drivers (per management commentary in Q2 and Q3 FY26 calls), the board could use one more director with operating tech depth. Naresh Chand Gupta (ex-Adobe India MD) is the only one with material tech-product experience.

Concerns that are real vs cosmetic

• Anjan Malik (promoter) chairs Risk Management. Statutorily allowed, but unusual — risk oversight at a publicly-listed company is more typically chaired by an independent director. Defensible because Malik has the longest operating memory and most domain knowledge, but worth flagging.
• 100% board attendance at every single meeting for every single director is statistically improbable for a 9-person board with five committees. Either meetings are tightly choreographed or some attendance is by video conference being recorded as physical presence. Not a violation, but a "too clean" data point.
• Simultaneous April 2024 refresh of five committee chairs suggests pre-coordinated restructuring rather than organic rotation. Net effect was more independence, so the outcome is positive.

5. The Verdict

Strongest positives. Two founders own 54.5% of the company and have never trimmed a share in 26 years. The whole-time founder takes ₹1.7 crore in salary, no bonus, no ESOPs — extraordinarily restrained. Both founders sit out every buyback, so every buyback transfers more economic interest to them at zero cost — yet they keep doing buybacks anyway, suggesting they believe the equity is worth more than the cash. Related-party register is clean. The board has been deliberately tilted toward independence under an independent Chair. Capital allocation is explicit, consistent, and shareholder-friendly: prefer buybacks over dividends, return essentially 100% of free cash flow.

Real concerns. The Group CEO's compensation is routed through the UK subsidiary, which legitimately reflects his location but reduces Indian disclosure transparency and creates transfer-pricing audit exposure. Anjan Malik (promoter) chairs Risk — a soft governance weakness. Tech/AI expertise on the board is thin against the company's stated AI-driven strategy. The April 2024 wholesale refresh of committee chairs warrants ongoing observation: did it improve governance, or did it install a board the founders find easier to work with?

Upgrade trigger. Adding one more independent director with deep AI/product-engineering operating experience, AND shifting Risk Committee chairmanship to an independent director, would push this to a clean A.

Downgrade trigger. Any change to the related-party regime that began routing material business through founder-owned vehicles, or evidence that the post-April 2024 board is rubber-stamping management rather than challenging it (current 100% attendance and 99.9% shareholder approval rates already lean this way), would push this to a B.

---

How the Story Changed

For two decades eClerx sold a story about industry-leading margins and Wharton-founder pedigree, and the story slowly stopped working — growth decelerated, margins drifted, the share register turned restless. In May 2023 the board handed the keys to Kapil Jain, the first non-founder CEO; a year later he formally rewrote the contract with investors: lower the margin band, fund a sales/hunting build, productise the catalogue, and earn back the right to be called a top-quartile compounder. Eleven quarters in, the rewrite is being delivered — revenue has compounded roughly 15% per year, the FY2026 EBITDA margin re-printed at the high end of the new band, and the founders have visibly stepped off the earnings call. Management credibility has clearly improved; the open question is whether AI productisation and onshore-restrictions risk can preserve the premium multiple now embedded in the stock.

1. The Narrative Arc

eClerx has lived four chapters: founder build (2000–2012), inorganic widening (2012–2021), professionalisation (2023–2024), and productised acceleration (2024–present). The pivots are unusually clean because most of them happened around the same set of acquisitions and one CEO handover, not a string of cosmetic relaunches.

Two observations matter more than the rest. First, almost every meaningful capability the current management is now monetising — the four verticals, the productised services suite, the Personiv F&A business, the European luxury foothold — was inherited, not invented. The current team's value-add has been to take a referral-driven, founder-dependent business and bolt on a hunting motion, productisation, and geographic delivery diversification. Second, the Q4 FY2024 strategy reveal was an explicit reset rather than a continuity statement — the margin band was cut by 400 bps, the founders publicly stepped back from earnings calls in the same session, and Kapil Jain laid out FY25, FY26-27 and FY28 priorities in the same slide deck. That's an unusually committal move from a company that had spent the prior decade refusing to give medium-term guidance.

2. What Management Emphasised — and Then Stopped Emphasising

The clearest way to see the strategy shift is to count words. The table below shows how many times each theme appears in each quarterly earnings call from Q3 FY24 (Kapil's first full quarter on the call) through Q4 FY26. The colour intensity tells you what management chose to spend airtime on.

Five patterns worth flagging.

Personiv vanished from the conversation. It was the single largest topic in Q3 FY24 (22 mentions) when the largest client in-sourced; from Q1 FY25 onward it does not appear once. That looks like containment by design — management decided the incident did not signal a trend and refused to keep relitigating it.

The 24–28% margin band became a verbal anchor. From Q4 FY24 onward every call references the band; even when results print at the top end (Q2 FY26 at 28.8%) or the bottom end (Q1 FY25 at 23.3%), management does not move the goalposts. That discipline is the single most important credibility signal in the dataset.

Productised services and AI moved from sidebar to centrepiece. "Productised services" went from zero mentions in Q3 FY24 to 21 in Q4 FY25 as Market360, Compliance Manager, GenAI360 and Roboworx CogniFlows became the standard framing. GenAI mentions are noisy but trend higher; the Q3 FY26 narrative shifts explicitly from "pilots" to "deployments" and the Q4 FY26 call describes the first large-scale Agentic AI contract.

Geography became a real lever, not a slogan. Until Q4 FY24 the company barely talked about delivery geography. The Q4 FY25 call (Peru live, Cairo opening) saw 18 geo-related mentions; Cairo customer expansions show up in Q3 FY26 and Q4 FY26 (Manila, Cairo, Fayetteville). This is a real change in delivery posture, not just commentary.

Cross-sell ("One eClerx") was talked about loudly in FY25 and then de-emphasised. It peaked at 14 mentions in Q2 FY25 (when the strategy was being sold to investors) and tapered to 1 in Q4 FY26 — by then the cross-sell results are being shown in numbers (Emerging segment growth, Analytics & Automation at USD 90M) rather than narrated.

3. Risk Evolution

The risk discussion has shifted from "BPO commoditisation and labour inflation" to "AI cannibalisation of own revenue base" and, in the latest quarter, "regulatory restrictions on offshore call centres". The legacy risks (banking spend cycle, fashion & luxury demand, FX) are still present but treated as cyclical rather than structural.

Three risks deserve the analyst's attention going forward.

GenAI cannibalisation. Through FY2024 management framed AI as a net opportunity (Kapil Jain on Q3 FY24: AI is "an opportunity to build proof points because we have domain, process and tech knowledge"). By Q4 FY26 the framing changed — AI is now embedded in client RFPs and "agentic" deployments displace headcount-led work. Management has not raised the alarm explicitly, but the increased emphasis on productised platforms and the AI training of 40% of the workforce are defensive moves dressed as offensive ones.

Onshore call restrictions. The Q4 FY26 call introduces a new disclosed risk — a US "proposed NPRM on offshore call restrictions" — that did not exist before. This is the first regulatory tail risk that could touch the CMT vertical materially, which is roughly a quarter of revenue and the fastest-growing in Q4 FY26 (+7% sequentially). Management says it is in "active dialogue with clients on contingency planning"; Cairo, Manila and Fayetteville expansion is partly a hedge.

INR/USD asymmetry. The Q2 FY26 record margin (28.8%) was 200 bps INR-aided; management called this out unprompted and warned Q3 would not repeat. That kind of honesty about transient tailwinds is unusual and useful, but the underlying point is that the high end of the 24–28% band is currently currency-flattered, not structurally earned.

4. How They Handled Bad News

There are three bad-news episodes in the period under review. In each, the gap between the language before and after is a useful credibility test.

The single most revealing moment in the dataset is Kapil Jain refusing to give a quantitative growth target while accepting a 400 bps margin cut (Q4 FY24, in response to Sandeep Shah of Equirus):

"It's just like in the volatile industries that I mentioned to you, the volatility that we see in the market — I have given the EBITDA margin guidance and we will continue to operate in that range. … Our aspirations obviously are to deliver double-digit growth."

Why it matters: a less disciplined CEO would have paired the margin cut with a flashy revenue target to soften it. Kapil took the margin pain, kept the growth aspiration directional ("double-digit"), and then proceeded to deliver +12.3% in FY25 and +17.9% in FY26 — under-promising twice in a row.

5. Guidance Track Record

The promises that matter for valuation are the multi-quarter ones — the margin band, the growth aspiration, the productisation roadmap, the geo diversification, the AI execution, and the Personiv recovery. The Q3 FY24 "modest Q4 growth despite Personiv" and Q2 FY26 "Q3 margin will be lower" are short-cycle promises that are useful as honesty checks.

Credibility score: 8 / 10. The deduction is not for missed targets — it is for two structural caveats. First, the FY26 high-margin print was meaningfully INR-aided (200 bps in Q2 FY26 alone), so the recurring power of the new band is not yet proven without a tailwind. Second, the M&A line in the May 2022 founder commentary ("we look very aggressively for companies… inorganic growth is an important vector") has quietly faded — large bolt-on M&A has not happened in the Kapil Jain era despite roughly INR 1,100 crore of cash on books at various points and successive buybacks instead. That isn't a broken promise so much as a quiet pivot away from inorganic ambition that investors who were modelling acquisitive growth should now discount.

6. What the Story Is Now

The current story has three components and the reader should weight them differently.

What the reader should believe. Kapil Jain is a credible operator who under-promises by design and stays inside guidance bands even when overshooting. The professionalisation of the sales motion (CRO, CMO, CO principal hires in May 2024) is now visible in numbers: top-10 client concentration has come down from 63% to 59% across two years, the Emerging segment is the fastest-growing slice, and Analytics & Automation has reached a USD 90M book without buying it through M&A. The productised services suite (Market360, Compliance Manager, Roboworx CogniFlows, GenAI360) is being recognised externally — Everest Group Leader in Capital Markets, Gartner Market Guide for Digital Shelf, Chartis category leader for CLM — which validates the productisation pivot was substantive, not branding.

What has been de-risked. Personiv-style client in-sourcing turned out to be the one-off management said it was. The 24–28% margin band has held for two consecutive years through a wage cycle, a senior-hire bulge, a strong-INR quarter and a weak-INR quarter — that's robust. Founder dependency is gone: the PD Mundhra / Anjan Malik handover went cleanly, and the founders have not micromanaged through the board.

What still looks stretched. The stock multiple. As of Feb 2026 the trailing PE briefly touched 35x and the stock fell 10% in a single week on technical/valuation concerns even though Q3 FY26 results were strong. The valuation premium implicitly bakes in the AI productisation succeeding at scale (the first large-scale Agentic AI contract is a Q1 FY27 deployment promise, not a delivered result) and the INR weakness persisting. The Fashion & Luxury vertical is six quarters into a slump that management says might have bottomed but has not yet inflected. And the proposed US restrictions on offshore call centres is a brand-new regulatory tail that touches the fastest-growing vertical (CMT) — Cairo, Manila and Fayetteville are the hedges, but they're not yet proven at scale.

What the reader should discount. Aspirational language about "top quartile" or "leadership across all verticals" — earned in some, still pending in others (Customer Operations specifically has been a slower compounder than BFSI or Emerging). The "we will be aggressive on M&A" theme from the founder era — three years of organic-only execution and capital being returned via buybacks and a bonus issue suggest M&A appetite is materially lower than the language implies. Any model assuming the FY26 high-end margin print extrapolates without an FX assist.

The shortest summary: the eClerx story used to be "great margins, slowing growth, founder-led" and is now "good margins, accelerating growth, professional management, AI productisation in progress, valuation richer than it used to be". The team has earned the right to be believed. The market has already paid for most of it.

---

Financials

eClerx is a small but unusually high-quality services business: revenue of ₹4,117 crore, operating margins in the mid-twenties, a balance sheet with almost no real debt, and free cash flow that has consistently exceeded reported net income over a decade. The stock used to trade like a quality compounder, and for a long time the financials supported that view. After a 72% drawdown from the February 2026 peak, the question on this tab is no longer "is this a quality business" — the data answers yes — but "what does the current price imply about the next leg of growth, margins, and capital allocation?"

1. Financials in One Page

A senior buy-side reader should leave this section knowing five facts. Revenue compounded at roughly 13% over a decade and is now growing in the high teens again. Operating margins gave back ten points from the 2016 peak as eClerx absorbed Personiv and Cognicor and digested wage inflation, but they have stabilised in the mid-twenties and ticked back up in FY26. Cash conversion is exceptional — cash from operations equalled 104% of operating profit in FY26 and free cash flow margin reached 18.4%. The balance sheet shows ₹385 crore of borrowings (most of which is the IFRS-16 lease liability) against ₹308 crore of treasury investments and a clean equity base of ₹2,561 crore. Valuation has compressed from a peak P/E above 80 to roughly 18× trailing earnings, which is below the company's own five-year average and inline with India mid-cap BPM peers despite a structurally higher return profile.

How to read these numbers. ROCE (return on capital employed) is operating profit divided by the capital the business actually uses — equity plus interest-bearing debt. A consistently high ROCE means the company earns far more on each rupee of capital than it costs to fund. P/E (trailing) is the share price divided by the last 12 months of earnings per share — a quick proxy for how much you pay for each rupee of profit, before any growth assumption.

The single financial metric that matters next is operating margin: eClerx's whole valuation case rests on whether the FY26 recovery from 24% to 26% is the start of a sustained mid-twenties regime (premium multiple justified) or a quarter of cost discipline before AI pricing pressure and wage cycles drag margin back into the low twenties.

2. Revenue, Margins, and Earnings Power

Revenue tells the story of two eClerxes. From FY15 to FY21, growth was anaemic — roughly 9% CAGR over six years — as eClerx's core capital-markets back-office franchise saturated and customer-operations clients shifted toward in-house and AI-led automation. From FY21 onward, two inorganic moves (Personiv on the creative-production side, Cognicor on AI-enabled customer-experience automation) plus a new wave of regulatory-driven outsourcing in BFSI pushed annual growth back toward the high teens. FY26 revenue of ₹4,117 crore is more than 2.6× FY20.

The margin chart is the more important one for an investor: it shows where the earnings power went and what came back. Operating margin peaked at 37% in FY16 — that is the margin of a niche, owner-operated capital-markets specialist with very little competition. As eClerx scaled into customer operations, then layered on acquired digital businesses with lower native margins, OPM compressed all the way to 22% by FY19. The post-Covid rebuild took OPM back into the 27–31% range. FY24-25 saw the next squeeze (wage inflation + Personiv ramp + clients renegotiating during AI noise) — OPM fell to 24%. FY26 stepped back up to 26%, with the second half of the year (H2 FY26) running at 27%.

The recent eight-quarter trajectory shows a real inflection. Quarterly revenue has gone from ₹782 crore (Jun 2024) to ₹1,107 crore (Mar 2026) — 41% growth across two years — while quarterly operating margin lifted from 21% to 26%. This is the operating-leverage signal underwriting the bull case: incremental revenue is dropping through at a higher rate than the FY25 average.

Earnings power is improving, not deteriorating. The FY24-25 margin trough is behind the company, and the operating-leverage on incremental revenue is real — but it is also the consensus view, which is why the next paragraph on cash flow matters more.

3. Cash Flow and Earnings Quality

What is free cash flow. Free cash flow (FCF) is the cash a business generates from operations after the capital expenditure needed to maintain and grow itself. Reported earnings can be flattered by depreciation choices, deferred taxes, working-capital releases, or one-time gains. FCF is the cleaner test: did real cash hit the bank?

eClerx passes this test cleanly. Operating cash flow has equalled or exceeded net income in every year of the last decade — the chart below makes the point visually. Over twelve years the company has cumulated ₹5,193 crore of operating cash flow against ₹4,180 crore of reported net income, a 124% conversion ratio. Free cash flow of ₹4,217 crore over the same period is 101% of net income — a near-perfect translation of accounting earnings into distributable cash.

The FCF margin tells the same story from the revenue side: 18-20% of every rupee of revenue ends up as free cash flow, after all working capital and growth capex. FY26 was a standout — ₹756 crore on ₹4,117 crore of revenue, an 18.4% FCF margin, up from 16.0% the year before.

The single distortion to watch is debtor days. Receivables ballooned from 60 to 88 days in FY24 (clients pushed payment terms, a few large BFSI accounts moved to longer cycles) and stayed elevated through FY25 at 86 days. FY26 brought debtor days back to 59 — collections have caught up, which is the principal reason operating cash flow grew 33% on 22% revenue growth.

4. Balance Sheet and Financial Resilience

The balance sheet is the easiest section to underwrite. eClerx has run with essentially zero net financial debt for a decade. The ₹385 crore reported as "borrowings" in FY26 looks alarming at first glance, but virtually all of it is the IFRS-16 lease liability for the company's delivery centres — capitalised because the accounting standard requires it, not because eClerx took on debt. Against that, the company holds ₹308 crore in investments and a substantial cash balance embedded in "other assets". Net financial debt is, for practical purposes, zero.

A simple resilience screen — borrowings to equity and to operating profit — confirms the picture. Borrowings are 15% of equity and just 37% of one year's operating profit. The interest expense of ₹42 crore in FY26 is covered 25× by operating profit; even if rates doubled the cover would remain comfortable. The company could clear all its reported borrowings with five months of operating cash flow.

The balance sheet adds flexibility, not risk. The only constraint is that eClerx's value is overwhelmingly in its people and client contracts, not in tangible assets — there is no hard floor to lean on if the operating story breaks.

5. Returns, Reinvestment, and Capital Allocation

The returns picture is the strongest argument for paying any premium for eClerx. ROCE (return on capital employed) was 35% in FY26, ROE 29% — both well above the 12-15% cost of equity for an Indian mid-cap services name. Yes, ROCE has compressed from the 50% peak of FY16 — but the entire compression is explained by a larger equity base (retained profits accumulating faster than they can be reinvested) and the goodwill from Personiv and Cognicor. On an incremental-capital basis, eClerx still earns returns most companies can only describe in a memo.

Capital allocation has been disciplined and shareholder-friendly. The dividend payout (when paid) is high, and management's preferred tool is buybacks — accretive when the stock was below ~₹1,500 and aggressive enough to keep the share count broadly stable through dilution from ESOP grants. FY26 financing outflow of ₹622 crore matched the entire year's free cash flow, indicating the company effectively returned all FCF to shareholders rather than hoarding cash.

Share count has been managed actively. Buybacks have offset bonus issues and ESOP grants. The FY26 bonus issue (which lifted equity capital from ₹47 crore to ₹92 crore) was a 1:1 bonus that doubled outstanding shares but was earnings-neutral. EPS growth therefore tracks net income growth closely.

The judgment is straightforward: management is returning excess cash sensibly, not masking weak economics. The reinvestment opportunities inside the company are limited (eClerx is people-and-contracts, not capex-led), and instead of building empire through expensive M&A, the company has chosen to compound per-share value through buybacks. That is the right answer for a 35%-ROCE services business with a saturated core.

6. Segment and Unit Economics

eClerx does not publish detailed segment financials in the same form as a global services firm. Reported business segments are Customer Operations, Financial Markets, and Digital (with Personiv as the largest part of Digital). From management commentary across FY25–FY26 results, the broad disclosed mix is:

The investor takeaway: Financial Markets is where the economics live. It is the segment with the highest margin, the longest customer contracts, and the strongest moat (specialist domain knowledge in capital-markets back-office that even Genpact and WNS underweight). It is also the segment where AI-led disruption risk is lowest in the next two years, because regulatory work and reference-data flows require auditable processes. Digital/Personiv is the lower-margin growth engine — the bet management is making is that creative-production volumes grow faster than they compress in margin. A reader who is bearish on eClerx is essentially bearish on the Digital mix shift; a reader who is bullish believes Financial Markets compounds at 15-20% with margin protection.

Geographic exposure is roughly 60% North America, 25% Europe, 15% rest of world. USD-linked revenue is therefore close to 85% — material rupee depreciation is a real tailwind on margin (offset partly by US wage inflation in onshore client-facing roles).

7. Valuation and Market Expectations

This is where the picture changes hardest. At ₹1,360 the stock trades at 18× trailing earnings. The five-year average P/E is closer to 24×, and the 2026 peak was above 80×. The valuation reset is a 70%+ compression of the multiple, not a deterioration of fundamentals.

Choosing the right multiple. eClerx is a stable-margin services business with very little debt and strong cash conversion, so the P/FCF and P/E multiples are the cleanest reads. EV/EBITDA is mechanically similar to P/E here because depreciation is small and net debt is roughly zero. P/B is less useful because the book value is mostly retained earnings rather than productive tangible assets — a 5× P/B is normal for a 29% ROE business and tells you almost nothing.

The history matters. Below is a rough P/E history pegged to fiscal-year-end share prices and trailing EPS — note the 2025–2026 spike to almost 80× and the subsequent collapse to 18×.

The current 18× is below the company's own historical mean and at the bottom of the post-Covid range. Whether that is cheap or fair depends entirely on the next two years' earnings.

Bear / Base / Bull at 18-month horizon

The exercise below anchors on a FY27E EPS of ₹88 (consensus revenue growth ~17%, margin steady, modest tax). Multiples reflect plausible ranges given India IT services peer comp.

External anchors: Emkay Global (May 2026) has a BUY with target ₹1,800 (≈ +32%). Trendlyne's aggregated 10-analyst consensus shows a stale ₹4,053 target that has not yet caught up to the drawdown. The Nomura April 2026 target of ₹2,220 sits between these two. The honest read is that consensus is mid-rerating: the new equilibrium is probably between Emkay's ₹1,800 and Nomura's ₹2,220, implying low-to-mid 20s P/E on FY27 earnings — exactly the base case above.

The stock is not expensive at 18× trailing for a 25%-margin, 29%-ROE business with mid-teens growth. It is also not the obvious bargain it looks like at first glance, because the post-Covid premium has been removed and not all of it deserved to come off. Valuation is fair-to-attractive on the base case; the asymmetry is positive but modest, with downside protection from the cash-flow base.

8. Peer Financial Comparison

The peer set is built from India-listed BPM/KPO/analytics specialists plus Genpact as the global pure-play benchmark. Coforge is a larger IT services hybrid with material BPM exposure (Cigniti); FSL is a similar-size BPM with consumer/healthcare mix; Datamatics is the closest mid-cap analogue by size; LatentView is a pure-play analytics overlap. Genpact is in USD — its row is labelled and converted is shown in the USD file.

The peer gap is the headline of this whole tab. eClerx earns the highest operating margin, highest ROCE, and highest ROE in the India peer set, by a wide margin, and trades at the cheapest P/E multiple of the four India peers (Datamatics is the only one within striking distance, and Datamatics is half the size with materially lower returns). Coforge gets a 36× multiple for slightly faster growth and lower returns; LatentView gets 30× for a smaller, lower-quality book. On a quality-adjusted basis eClerx looks materially under-priced versus its India peer set today.

Genpact is the spoiler. At 10× US earnings on $5B revenue, Genpact prices BPM scale at a sharper discount than India multiples imply — and a global investor looking at "BPM" as a category will frequently anchor there. The India premium for eClerx is therefore not a tailwind to the multiple; the right read is that eClerx deserves to trade above Genpact on returns and growth, but the gap will likely cap at high-twenties P/E rather than mid-thirties.

9. What to Watch in the Financials

What the financials confirm: eClerx is a high-quality, cash-generating, debt-light, capital-allocator-discipline business. The history shows a real franchise — twelve years of positive free cash flow, ROCE never below 21%, and a balance sheet that has never been a source of risk.

What the financials contradict: the market's 2025 thesis that this was a hyper-growth platform. Revenue growth has been good — 13% over a decade, accelerating to 17% recently — but it is not the 25-30% growth that justified an 80× multiple. The drawdown to 18× is the market correcting that mispricing, not pricing in fundamental deterioration. The financials do not support either the old peak multiple or a much lower multiple than today.

The first financial metric to watch is the FY27 operating margin trajectory. If H1 FY27 holds at or above 26% OPM with mid-teens revenue growth, the base-case ₹1,936 anchor is the right one and the stock screens fair-to-cheap. If OPM slips back toward 23% on Personiv mix or BFSI pricing pressure, the fair value range moves toward ₹1,200–1,400. Everything else on this page is secondary to that single question.

---

Web Research — What the Internet Knows

The Bottom Line from the Web

The roughly 72% headline drawdown from ₹4,950 to ₹1,345 widely cited in the press is half mechanical — a 1:1 bonus issue allotted on 16 March 2026 (record date 13 March 2026) doubled the share count, so the pre-bonus price of ~₹3,153 became ~₹1,576 overnight before any fundamental selling. The true adjusted decline from the post-bonus 52-week high of ₹2,498 to today's ₹1,345 is closer to −46% — still severe, but it sits on top of a record FY26 (revenue +22.3%, net profit +30.5%) and a unanimously bullish sell-side: nine analysts, Buy consensus, ₹1,859 average target (+37%), with Nomura at ₹2,220 (+64%) reiterated on 4 May 2026.

Sources: scanx.trade — Bonus Allotment, businesswire — FY26 Results 15 May 2026, marketscreener — Consensus, Investing.com — Analyst targets

What Matters Most

1. The price collapse is half optical — bonus issue masks the real drawdown

Source: scanx.trade — Bonus Allotment confirmation, businesstoday — pre-bonus close.

2. FY26 results were strong, not weak

Source: businesswire — FY26 results press release, 15 May 2026, Yahoo Finance Q4 FY26 highlights.

3. FCC NPRM on offshore call centers is now real — adopted 26 March 2026

Sources: Potomac Law — FCC Proposes New Rules, 30 April 2026, Brownstein — FCC Moves to Address Offshore Call Centers, Ecomm-alliance — Offshore Call Centers NPRM, 31 March 2026.

4. Sell-side consensus is unambiguously bullish

Nine analysts cover the stock; consensus is Buy. Average 12-month target ₹1,859 (+37%), high ₹2,220 (+64%), low ₹1,550 (+14%). MarketScreener notes: "sales forecast has been frequently revised upwards" and "analyst opinion has improved significantly over the past four months."

Source: Investing.com — Consensus, 9 of 9 Buy / 0 Hold / 1 Sell, MarketScreener Consensus.

5. Promoter holding INCREASED during the drawdown — and pledge is still zero

Promoter holding bumped from 53.81% to 54.52% in Q4 FY26 — PD Mundhra moved from 26.85% to 27.21%, Anjan Malik from 26.84% to 27.20%. Promoter pledge has stayed at 0.00% across every reporting period since at least Dec 2023. In a small-cap drawdown environment this is the single most reliable governance signal.

Source: Trendlyne — Shareholding history, Tijori Finance — Detailed shareholding, Finology — Promoter pledge history.

6. Capgemini-WNS deal — CEO declines to engage

Source: ECLERX Q1-2026 Earnings Call transcript via Alpha Spread.

7. Agentic AI organization unified under former BFSI head

On 20 May 2026 eClerx announced a unified AI leadership organization to accelerate its enterprise AI strategy. John Flowers, the former Head of BFSI at eClerx, was named to lead it. Roboworx CogniFlows is the company's foundational Agentic AI platform. Independent coverage confirms the company has deployed agentic AI for KYC at a multinational financial institution and for QA on a global telecom — both case studies on the company site. Analyst commentary from ainvest.com cites a $10M R&D investment yielding five AI solutions and 19.5% YoY revenue growth in Q1 FY26.

Sources: Morningstar — eClerx Unifies AI Leadership, 20 May 2026, ainvest.com — Strategic Position in Capital Markets Services, 28 August 2025, eClerx — KYC Agentic AI case study.

8. Onshore/near-shore expansion is the FCC hedge — Cairo and Lima opened

eClerx opened a Cairo, Egypt delivery center (announced 9 June 2025, MoU with ITIDA for multilingual support, 18 November 2025) and a Lima, Peru delivery center. Combined with the existing Fayetteville, NC US onshore site and Manila, these are the geographic options the company would lean on if the FCC NPRM moves to a final rule. The expansion timing suggests management saw the regulatory tail risk before it materialized.

Source: businessnewsthisweek.com via Tracxn — Cairo and Lima announcements.

9. Highest-ever deal wins, but no clean ACV vs TCV disclosure

Dolat Capital upgraded eClerx to Buy in May 2025 citing "highest-ever deal wins" of $51M ACV in Q4 FY25; TTM ACV +24% YoY at $140M. Q4 FY26 ACV $46.1M. The Analytics & Automation sub-segment has now scaled to ~$90M and "is expected to outpace overall company growth." Emkay Global target ₹1,800 (May 2025). Note: the disclosed metric has not been formally defined (TCV horizon vs ACV) in any press release the team could locate — this remains a Forensic team yellow-flag.

Sources: NDTV Profit — Dolat upgrades to Buy, 16 May 2025, Moneycontrol — Emkay Buy target ₹1,800.

10. Industry-wide recognition: Everest Group PEAK Matrix Leader 2025

eClerx was named a Leader and Star Performer in Everest Group's Capital Markets Operations Services PEAK Matrix® 2025 and a Major Contender in the Marketing Services PEAK Matrix 2025. Inclusion in Forrester's "AI Consulting Services Landscape, Q3 2025" was confirmed. These are independent analyst certifications that the niche positioning is being recognized externally, not just claimed by management.

Sources: eClerx — PEAK Matrix 2025 announcement, Yahoo Finance — Forrester AI Consulting Landscape Q3 2025.

Recent News Timeline

What the Specialists Asked

Governance and People Signals

Founders remain the anchor. Co-founders PD Mundhra (Executive Director) and Anjan Malik together hold 54.41% — they have been adding, not selling. Family-member holdings (Supriya Modi 0.05%, Vijay Kumar Mundhra 0.07%) are immaterial.

CEO Kapil Jain — Appointed Managing Director & Group CEO from 1 May 2023 with a five-year term to May 2028. Prior experience cited as Genpact UK BPO. Comp routed through eClerx Limited UK; no SEBI scrutiny located. Independent CEO ratings (Comparably) are mixed-to-weak, but the rating data is thin.

Board refresh April 1, 2024 — Five committee chairs rotated: Kekre as Chair, Majmudar (Audit), Naval Bir Kumar (NRC), Naresh Chand Gupta (CSR), Malik (Risk). Public disclosure framing is "completion of tenure" — scheduled rotation, not dissent.

Promoter pledge: 0.00% across every quarter since Dec 2023. In an Indian mid/small cap drawdown this is the single most reliable governance signal — when promoters are squeezed, pledges precede everything else.

Industry Context

The most important non-eClerx development is the FCC NPRM. It is no longer hypothetical — the rulemaking was adopted on 26 March 2026 at the FCC's Open Commission Meeting. The comment period now drives timing. Three things matter for sizing the impact:

1. Scope — direct targets are telecom/cable/CMRS/VoIP/DBS providers and their affiliates. eClerx's CMT clients are the providers, so a disclosure mandate or onshore-routing percentage would push their procurement decisions, not eClerx's directly.
2. Form of the final rule — disclosure-only is a much smaller economic impact than a hard percentage cap on offshore calls. Both are on the table per the Potomac Law and Brownstein analyses.
3. Geographic hedge — Cairo (June 2025) and Lima (Q1 2025) appear to be the company's pre-emptive bet that some onshore/near-shore migration is coming. The Fayetteville, NC site is the existing US footprint.

Capgemini-WNS is the other structural shift. Capgemini's 2025 acquisition of WNS put a tier-1 systems integrator directly into eClerx's capital-markets niche. The Q1 FY26 CEO non-answer on this question reads as guarded confidence, not concern, but the team should track tier-1 bank deal wins/losses for the next 6-18 months.

GCC build-out at named eClerx clients is the slow-burn substitution risk. Infosys BPM's own November 2025 commentary confirms BFSI GCCs in India are now "centres of excellence" rather than cost arbitrage. With top-10 client concentration at ~55-59%, even one large captive build at a single bank can move eClerx's growth. The company's stated target is to reduce single-client concentration below 15% by 2026.

The Indian BPM sector is growing at 8-10% globally and 12-15% in digital/analytics sub-segments. eClerx's FY26 INR growth of 22% is therefore share-gain growth, not sector growth — which is unusual for a small-cap selling off this hard.

---

Web Watch in One Page

eClerx is a Rs.12,706 crore market-cap, founder-controlled specialist KPO that just printed its strongest fiscal year on record (FY26 revenue Rs.4,117 Cr +22%, PAT Rs.706 Cr +30%, FCF Rs.756 Cr +40%, operating EBITDA 25.5%, ROCE 35%) yet trades at 18x trailing on a 52-week low after a half-mechanical, half-real ~46% post-bonus de-rate. The verdict is Lean Long, Wait For Confirmation — the bull case is built on the cash machine and owner-operator alignment; the binary question for a 5-to-10-year holder is whether the productized-IP layer (Roboworx, Compliance Manager, Market360, GenAI360) earns AI productivity as new outcome-priced revenue, or cedes it as price concessions on the 91% time-and-materials book.

The five active watch items below track the report's most thesis-resolving signals. Three (AI revenue disclosure, margin band, capital-return discipline) test whether the bull setup earns the productized-services multiple. Two (FCC final rule, Capgemini-WNS) track the two named structural threats — a regulated 45%-of-revenue vertical exposed to a US rule with no offshore offset, and a Tier-1 integrator now sitting inside the BFSI niche after Capgemini's July 2025 acquisition of WNS. Together they cover the only failure modes the report ranks as Highest or High.

Active Monitors

Rank	Watch item	Cadence	Why it matters	What would be detected
1	Agentic-AI / outcome-priced revenue disclosure	Daily	Revenue per employee has been flat at Rs.20.5 lakh for three years against a 91% T&M book; whether productized IP earns AI productivity as new vendor revenue is the single 5-to-10-year binary that decides whether the multiple re-rates to 25-30x or converges to Genpact 10x.	A quantified outcome-priced or agentic-AI revenue line, a named large agentic-AI client win, revenue-per-employee disclosure, or fresh commentary from CEO Kapil Jain or AI lead John Flowers (appointed 20 May 2026) on monetising AI productivity.
2	Operating EBITDA margin band and FY27 sequential growth	Daily	Two consecutive quarters below 24% would refute the durable 24-28% band the entire bull case (and Nomura's Rs.2,220 target) is built on. Q1 FY27 (projected 6 Aug 2026) is the only hard-dated catalyst inside 90 days and the wage-cycle low quarter.	Quarterly results and transcripts disclosing operating EBITDA margin, sequential USD/INR revenue growth, ACV TTM bookings vs the ~$170M run-rate, segment margin commentary, FY27 guidance revisions, or sell-side EPS revisions.
3	FCC NPRM 26-16 offshore call-center final-rule path	Daily	Customer Operations / CMT is the largest vertical at ~45% of group revenue with no regulatory tailwind. A hard offshore cap (the 30% reference point) inside 12 months drives 5-7 pp of group margin compression before Cairo, Lima and Fayetteville reach scale. Sell-side has not modelled it.	Federal Register publication, comment/reply deadlines, the form of any compromise text, FCC chair signaling, substantive industry filings (NASSCOM, CTIA, USTelecom), final-rule adoption, or analyst quantification of CMT exposure.
4	Capgemini-WNS BFSI wallet-share flanking move	Daily	Financial Markets is the only true wide-moat segment at ~35% of revenue. A 10 pp wallet-share shift at the top-3 banks costs 5-6% of group revenue. The CEO declined to engage on this risk in Q1 FY26; the FY16-FY19 telco episode shows the niche has been broken before.	Named Tier-1 bank wins for Capgemini-WNS at JPMorgan, Citi, HSBC, Barclays and other eClerx incumbents; cross-sell commentary from Capgemini IR; eClerx top-10 client concentration trajectory; GCC captive insourcing announcements.
5	Capital-return discipline: buyback engine, founder behavior, M&A drift	Weekly	The buyback engine has returned ~Rs.2,930 Cr over FY18-FY26 with founders sitting out every round so promoter holding compounded from 53.61% to 54.53% for free. The last buyback expired Dec 2025; the FY27 re-up, the use of post-bonus cash, and the avoidance of a Capgemini-WNS-style transformational deal are the structural per-share compound tests.	Fresh buyback or tender-offer authorisation, promoter pledge or share-sale activity, quarterly promoter-holding pattern, acquisition announcements above Rs.100 crore, related-party disclosures, CEO succession or board changes, AGM proceedings and dividend declarations.

Why These Five

The report's most important open questions distill to one binary, one durability test, two structural threats, and one alignment proof. Monitor 1 (agentic-AI revenue disclosure) is the binary — the failure-mode table ranks it tied for Highest severity, and the long-term thesis explicitly says a reader who tracks only one number for the next eight quarters should track revenue per employee. Monitor 2 (margin band) is the durability test that gives the bull case its first hard read on 6 Aug 2026 and resolves whether the H2 FY26 27% margin is structural or INR-flattered. Monitors 3 and 4 (FCC NPRM, Capgemini-WNS) are the only two structural threats the moat and verdict tabs flag at High severity — the regulated 45%-of-revenue vertical exposed to a US rule with no offshore offset, and a Tier-1 integrator now sitting inside the BFSI niche with a bundled sales motion eClerx structurally cannot match. Monitor 5 (capital-return discipline) is the alignment proof — the founder non-participation buyback structure is the bull case in concentrated form, and a transformational acquisition or estate-planning block sale is the failure mode that breaks the 5-to-10-year alignment thesis at the structural level. Other report items (FY26 annual report KAM resolution, Fashion & Luxury inflection, INR normalisation) are real but either time-boxed inside Monitor 2's coverage or lower severity than the items chosen.

---

1. Where We Disagree With the Market

The sharpest disagreement is this: the consensus is paying for a productized-IP layer that has not shown up in the only metric that would prove it. Sell-side is unanimously Buy (8 of 9, average target ₹1,859 implying +37%, Nomura ₹2,220 at +64%) and is implicitly pricing eClerx against the India BPM peer set (Coforge 36×, LatentView 30×, Datamatics 19×) where 18× trailing looks cheap. But revenue per employee has been flat at ₹20.5 lakh for three years against 91% time-and-materials revenue, no quantified agentic-AI revenue line exists, and global peer Genpact separately discloses $1.2B (23.7% of revenue) as Advanced Tech Solutions. Strip out the productized-services premium baked into consensus targets and eClerx is a high-quality generalist KPO whose right anchor is Genpact at 10× — not Coforge at 36×. We are not contrarian on the asset; we are contrarian on the multiple denominator the market is using to value it.

A second, narrower disagreement sits inside the FY26 margin print. Consensus reads the H2 FY26 27% margin as evidence the 24–28% band is structural; management itself called Q2 FY26 28.8% margin 200 bps INR-aided unprompted. The variant read is that consensus is anchoring base-case FY27 EPS on a margin that includes a currency tailwind that may not repeat.

2. Variant Perception Scorecard

The score is moderate, not extreme. Consensus is clear and well-documented (eight Buys, Nomura just raised FY27 EPS 2.4%, MarketScreener notes opinion "improved significantly over the past four months") — that is what makes the disagreement audit-able, but it also means a lot of smart sell-side capital is on the other side. Evidence strength is medium-high because the load-bearing data points — flat revenue per employee, the Genpact AI revenue benchmark, the bunched analyst-target distribution, the management-unprompted INR call-out — are each documented in the upstream tabs. Resolution is concentrated in a narrow 6–9 month window: Q1 FY27 print (Aug 6), the FY26 annual report (Jul-Aug), and the first quantified AI revenue disclosure (target Q1-Q3 FY27).

3. Consensus Map

Two of these consensus views (margin band; bonus-issue mechanics) are well-grounded; we do not contest them. Two more (top-10 trajectory; FCC tail) are observation-based but rest on a single interpretation of an ambiguous signal. The most monetisable disagreement sits where consensus is highest — the multiple anchor and the productized-IP credit baked into it.

4. The Disagreement Ledger

Disagreement #1 — the multiple anchor. Consensus would say: eClerx earns 25.5% Op EBITDA and 35% ROCE versus India peers averaging 17-20% margins and 17-23% ROCE; that earns the specialist multiple, and 18× trailing is cheap because 22-25× is the historical mean. Our evidence disagrees because the specialist label has not shown up in revenue per employee for three years, the 91% time-and-materials book is not different in mix from generalist BPM, and the global pure-play peer Genpact discloses $1.2B AI revenue separately while eClerx discloses zero. If the productized-IP layer fails to print as quantified revenue, the multiple should converge to Genpact's 10× over an AI-deflation cycle. The market would have to concede that the "specialist" frame is supported by historical returns (true) rather than by a measurable IP layer (unproven). The cleanest disconfirming signal is the first quantified outcome-priced revenue line ≥5% of group revenue.

Disagreement #2 — the top-10 trajectory. Consensus would say: top-10 falling from 64% to 59% during +22% growth is textbook diversification. Our evidence disagrees because the same number is equally consistent with quiet wallet-share migration — Capgemini's July 2025 acquisition of WNS placed a Tier-1 integrator directly inside the BFSI niche, the CEO refused to engage on the Q1 FY26 call ("I wouldn't want to comment on the competition"), and Personiv's largest client repeated the FY16-style $8M loss pattern in FY24. The market would have to concede that the headline trajectory is consistent with two opposite stories and the CEO's silence on the competitive question is informative. The disconfirming signal is two consecutive quarters of top-10 ticking back above 62% or a named Tier-1 bank disclosing a Capgemini-WNS bundled win.

Disagreement #3 — the FX-cleaned margin. Consensus would say: FY26 25.5% operating EBITDA with H2 at 27% is the new sustainable band. Our evidence disagrees because management itself called Q2 FY26 28.8% margin "200 bps INR-aided" unprompted — the cleanest possible self-disclosure that part of the recovery is currency. With ~85% USD-linked revenue and the FY27 hedge book pinned at ₹89/USD, an INR rally or even normalisation strips ~80 bps from structural margin. The market would have to concede that the run-rate is closer to 24-25% than 26-27% — putting consensus at the band floor, not the band middle. The disconfirming signal is the Q1 FY27 print on Aug 6: margin held above 25% on a wage-cycle low quarter with normalised INR would refute the variant; a print below 24% confirms it.

Disagreement #4 — implementation drag. Consensus does not address this because consensus is sell-side, which has no implementation constraint. Our evidence is that 20-day ADV is ₹3.13 Cr against a ₹12,706 Cr market cap, the promoter block is structurally non-lendable, and the stock is not on the NSE F&O list. The bull setup may be analytically right and still produce no marginal buyer at size — capping the multiple-rerate path that ₹1,859 average targets imply. The disconfirming signal is sustained ADV doubling above ₹6 Cr per day for three months post-bonus or F&O inclusion.

5. Evidence That Changes the Odds

The strongest single piece of evidence is the Genpact disclosure benchmark juxtaposed with eClerx's silence on AI revenue. The most fragile is the FX call-out — useful as a disclosure signal, but uncertain because INR could continue weakening and mask the underlying margin question. The most durable is the flat revenue per employee: it is the metric on which consensus's bull case and our variant case will both be settled, regardless of how INR or the multiple debate evolves.

6. How This Gets Resolved

7. What Would Make Us Wrong

The fairest version of the bull case is that we are wrong on three points at once.

First, consensus may be right that revenue per employee is the wrong metric. A genuine productized-services pivot would show up first in segment-margin disclosure and outcome-priced contracts, not in the blended revenue/headcount ratio. The unified AI organisation under John Flowers (announced May 20, 2026), the Q4 FY26 large-scale agentic-AI contract close, and the absence of any forensic flag in the unbilled work suggest the IP layer is being built — it is just not yet at scale. If the Q1 FY27 call discloses a productized-services revenue line above 5% of group revenue, our central variant collapses fast, and the India peer-anchor multiple is the right denominator after all. The cleanest concession would be that we under-weighted management's stage-setting and over-weighted the absence of disclosure.

Second, the top-10 concentration trajectory could simply be diversification, full stop. ACV +23% YoY to $170M, with quarterly bookings sustained at $40-50M, is hard to reconcile with quiet wallet-share leakage at the top end. If Q1 and Q2 FY27 print top-10 continuing to drift toward mid-50s while ACV holds, the wallet-share-leakage variant fails the data — and the CEO's Q1 FY26 non-answer was simply CEO discipline about not commenting on a specific competitor. We would have over-read silence as disclosure.

Third, the FX-cleaned margin debate may be a non-issue if the INR continues to weaken. Most India IT and BPM names have benefited from secular INR depreciation for two decades; treating the FX tailwind as transitory rather than structural may itself be the wrong frame. If Q1 FY27 prints above 25% margin on continued INR weakness, the disagreement still holds technically but loses operational relevance for the next 12 months.

The implementation drag is the variant we are most confident about because it does not require any forecast — ADV, F&O listing, and promoter lock are observed states, not predictions. The risk is that the post-bonus float expansion organically doubles liquidity over the next 6-9 months and the F&O committee adds eClerx to the permitted list. Either would weaken this point.

The first thing to watch is the Q1 FY27 print on August 6, 2026 — specifically whether the earnings call discloses a quantified outcome-priced or agentic-AI revenue line. The margin number resolves the FX sub-debate; the disclosure (or its absence) resolves the multiple-anchor debate that drives every other disagreement on this page.

---

Liquidity & Technical

eClerx looks like a midcap on the screen — ₹12,706 crore market cap, listed on NSE and BSE — but trades like a small cap that the float forgot. Over the last sixty sessions the stock has averaged barely 18,600 shares a day in value terms, roughly ₹3.13 crore (≈ $330k), and the technical regime is the kind of post-parabola wreckage where momentum, trend, and volatility all point the same direction. The job of this page is to make both halves of that picture concrete: what size a fund can actually move, and what the tape is telling a reader who just closed the Financials tab on a stock that has lost 72% of its value year-to-date.

1. Portfolio implementation verdict

Liquidity, not conviction, is the binding constraint on this name. A five-day clip at 20% of ADV clears only about ₹2.84 crore of value — call it 0.022% of market cap — so a normal mid-cap fund cannot accumulate or exit a meaningful weight without becoming the tape. On top of that, the technical setup is bearish: price is 61% below its 200-day moving average after a March death cross, MACD has just rolled negative again from an oversold bounce, and the 30-day realized volatility is sitting above the 5-year 80th percentile.

2. Price snapshot

The stock is essentially pinned to its 52-week low after a 72% collapse from a February 2026 all-time high of ₹4,945. Realised volatility is running well above the long-run middle of the range — risk premium is being demanded, not extended.

3. The critical chart — full-history price with 50/200-day SMA

Price is decisively below the 200-day — last close ₹1,360 against an SMA200 of ₹3,452, a 60.6% gap that takes months of trend repair to close. This is a confirmed downtrend, not a sideways regime.

4. Relative strength versus benchmark and sector

A like-for-like relative-strength chart against an Indian benchmark and sector is not built into this dataset — the underlying technical pipeline benchmarked against SPY rather than an India-domiciled ETF, and the sector peer basket is empty. We therefore make the comparison in returns terms rather than a rebased line.

The Nifty IT and Nifty 50 numbers in the table are approximate market readings and not pulled from this dataset, but the order of magnitude is the point: eClerx has underperformed both the broad index and the IT cohort by 60–70 percentage points over the past year. Relative strength is the worst in years, and that gap is still widening — the post-crash bounce stalled at the 50-day, not at the 200-day.

5. Momentum — RSI(14) and MACD histogram

RSI is 35 and falling, sitting just above its oversold line of 30 after a brief recovery from the crash low of 12.7 in mid-March. MACD histogram had turned positive on the April–May bounce but has just flipped negative again over the last two weeks, which is the textbook "bear-flag completes" signature: a momentum recovery that fails before the price reclaims its longer averages. Near-term (1–3 month) momentum has rolled back over.

6. Volume, volatility, and sponsorship

The biggest absolute volume days of the year clustered around the late-November to early-December run-up and the late-January peak — the rally was bought, but the subsequent waterfall through March–April did not produce a panic-volume capitulation day. Distribution was orderly rather than climactic, which is not the kind of footprint that usually marks a durable low.

The percentile context from the 10-year history is: calm regime under 25%, normal 25–47%, stressed above 47%. Today's reading of 49.8% just clears the "stressed" line, and the spike to 203% in mid-April marks the post-ATH crash itself. The market is still demanding a wider risk premium than normal, even as the crash decelerates.

7. Institutional liquidity panel

This section is for funds, not retail. The question is straightforward: can this stock absorb real institutional size?

A. ADV and turnover

A turnover of roughly 5.6% per year on a ₹12,706 crore market cap is consistent with a deep-promoter, buyback-shrunken float — eClerx has repurchased substantial equity over the last several years and the public float that remains trades thinly. ADV of about ₹3.1 crore is what you would expect from a much smaller listing.

B. Fund-capacity matrix

Read the row literally: at 20% of ADV — already an aggressive participation rate — a fund can clear ₹3.13 crore over five sessions. Reverse the math and that supports about ₹62.5 crore of total AUM if eClerx is to be a 5% position, or ₹156 crore at a 2% weight. For any fund larger than roughly ₹150–200 crore, a benchmark-style weight in eClerx is simply not implementable inside a normal participation budget.

C. Liquidation runway from realistic position sizes

A 0.5% of market cap position takes more than five trading months to fully exit at an aggressive 20% participation rate. A 1% position takes nearly a year. There is no realistic institutional sizing that does not turn the fund into the market on exit.

D. Price-range proxy

The 60-day median intraday range is 4.5% of price, well above the 2% threshold that flags meaningful impact cost. Combined with one zero-volume day in the last 60 sessions, an institutional execution desk should expect non-trivial slippage on any clip larger than a single ADV.

Bottom line: the largest size that clears the five-day threshold at 20% ADV is around 0.022% of market cap (≈₹2.8 crore). At a more conservative 10% participation it falls to 0.011% (≈₹1.4 crore). Liquidity, not view, is the gating constraint here.

8. Technical scorecard and stance

Stance — bearish, three-to-six-month horizon. The trend is broken, momentum has just rolled back over from a failed bounce, and volatility is still elevated. We would want to see a reclaim of ₹1,750 — above the collapsed 20/50-day cluster — held on a weekly close before considering that the post-crash low is in. Conversely, a break of ₹1,340 on a daily close would confirm the next leg lower and put the 2019–2020 lows around ₹700–800 back on the table. The tape has front-run any fundamental disappointment — whatever the Financials tab argues about earnings power, the market has already discounted a far more severe scenario, and the burden of proof has shifted to the bulls.

Liquidity is the constraint. The correct action for an institutional generalist is watchlist only at current size — a meaningful position would have to be built over many weeks at sub-10% participation, and the trend gives no reason to start that process today.

Notes and caveats

• Liquidity figures are indicative. Market cap was sourced from the Financials snapshot (₹12,706 crore at the 2026-06-10 close), not the technical feed; treat to two significant figures.
• No India-domiciled benchmark series in this dataset. The relative-strength comparison versus Nifty 50 and Nifty IT uses approximate, off-dataset readings to set the order of magnitude; treat as directional, not precise.
• Median intraday range of 4.5% materially overstates impact cost relative to a "normal" mid-cap and should be priced into any TWAP/VWAP plan.

---

Short Interest & Thesis

Short interest is not decision-useful for ECLERX. India does not publish security-level aggregate short interest, so there is no official figure to anchor a positioning view. No credible short-seller report, activist short campaign, or accounting allegation specific to eClerx has surfaced in prior research, and forensic work returned a "Watch" verdict (22/100) with no red flags. The actionable insight is the inverse: with promoters at 54.5%, domestic institutions ~25% and FIIs ~10% of a ₹12,706 crore market cap, the float is structurally hard-to-short — a 20-day ADV of ~20,900 shares (~₹3.13 crore) means even a small short position would be unwindable only over many sessions.

Why "official short interest" doesn't exist for this name

eClerx trades only on Indian exchanges (NSE primary, BSE secondary). The Indian framework treats security-level outstanding short positions differently from the US/UK regimes that institutional analysts are used to seeing.

The data pipeline confirms this: zero reported short-interest rows, zero short-sale volume rows, zero public net-short disclosures, zero borrow-pressure rows, and zero peer-context rows were staged for ECLERX. This is a structural feature of the market, not a data-collection gap.

Inferred short capacity — what the float will actually allow

In the absence of reported short interest, the relevant question is whether anyone could run a meaningful short here. Three constraints — float composition, lendable supply, and ADV — say no.

The promoter block (Mundhra and Malik, 54.53%) is locked: no founder selling in 26 years, promoter pledge 0.00% every quarter since Dec 2023, and the promoter percentage has risen through non-participation in buybacks. That stake is functionally non-lendable. Domestic mutual funds hold ~26% (HDFC AMC alone 8.4%) — Indian mutual-fund stock-lending is permitted but is a small, opaque channel. FIIs hold ~10% and are the most plausible source of lendable supply, though there is no public security-level borrow data to size it.

The ADV constraint sharpens the picture further. Over the last 20 sessions ECLERX averaged 20,902 shares per day (₹3.13 crore in value); over 60 sessions it averaged 18,607 shares (₹2.87 crore). ADV/market cap is ~0.025% — the technicals page explicitly calls liquidity, not conviction, the binding constraint.

The point is asymmetric: any meaningful short position would (a) need to find lendable inventory from a thin pool, and (b) face many sessions of ADV exposure to cover. This is not a name where a US-style crowded-short setup can build silently.

Public short-thesis evidence — what's there, what isn't

There is no public credible short-thesis ledger for ECLERX. Prior forensic research explicitly searched for short-seller reports, fraud allegations, and activist short campaigns against eClerx across general-web, Reuters, Fool, and CNBC scopes; the only "short-seller" hits were generic Motley Fool commentary about Luckin Coffee, not eClerx.

The two items a thoughtful skeptic might still build a thesis around are the forensic yellow flags: the FY25 step-up in unbilled receivables (from ₹207 Cr to ₹294 Cr, 7.1% → 8.7% of revenue) and the Rule 11(g) audit-trail gaps across four accounting systems for most of FY25. Neither rises to a published short thesis today; both are watch-items rather than allegations.

Borrow & locate evidence — unavailable

No public security-level borrow cost, utilization rate, lendable-supply, rebate-rate, or hard-to-borrow indicator is available for ECLERX. The NSE SLB segment publishes outstanding positions at segment level only; broker-internal locate desks do not publish a public hard-to-borrow list comparable to the US tape. The pipeline staged zero borrow-pressure rows, consistent with this.

What can be inferred without official data: given (a) a 54.5% locked promoter block, (b) the absence of single-stock futures on the NSE F&O list, and (c) ADV that clears under ₹3.2 crore per day, locate friction would be the binding constraint on any sized short attempt, not borrow cost. This is an inference, not a measured rate.

Tape signals — squeeze and de-risking footprints

In the absence of position data, the only positioning signal available is the tape itself. The technicals work flagged one squeeze-like session on the way up, but the broader picture is unwind, not crowding.

The August 2025 +9% session is the only episode in the recent history that looks like a squeeze pattern (gap higher on outsized volume after a downtrend leg). Read alongside the structural locate friction, it is more parsimoniously explained as forced-buyer mechanics from an illiquid float than as evidence of a covered short book. The post-February 2026 decline is dominated by post-bonus de-rating and high realised vol — the conventional read is long-side de-risking, not short-side accumulation.

Peer / sector context

No public peer-level short-interest comparison is possible because peer Indian IT-services and BPM names face the same regime. US-listed peers (Genpact GENPACT, WNS Holdings WNS, ExlService EXLS, Concentrix CNXC) do report FINRA short interest, but those are not a clean peer-context for ECLERX — they are listed in a different regime, with different float profiles, different index inclusion, and different borrow mechanics. Citing their short-interest figures alongside ECLERX would imply a comparability that does not exist.

Evidence quality and limitations

Bottom line for the PM

The short-interest lens does not change the ECLERX investment case in either direction. There is no measurable crowded-short, no public credible short thesis, no borrow-pressure signal, and the float is structurally hard-to-short. The only forensic items worth keeping in view are the FY25 unbilled-revenue step-up and the Rule 11(g) audit-trail gap — neither has been weaponised by a short-seller, but both are the most plausible building blocks if one ever is. Sizing and entry should be driven by the liquidity and trend work on the technicals page, not by an inferred positioning view.